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ABSTRACT 
Radiotherapy is a type of cancer treatment to suppress tumour growth by employing 
ionising radiation. External beam radiation is the most common form of radiotherapy 
and uses ionising radiation such as photon and electron beams. Megavoltage 
electron beams can be used to treat relatively superficial tumours of less than 5 cm 
depth such as skin, scalp, chest walls, breast, and nodal boost. In the radiotherapy 
process, the treatment planning system plays an important role in simulating dose 
distributions in a patient that would be delivered by the treatment machine. 
Conventional planning algorithms are based on relatively simple beam models: beam 
profiles are measured in homogeneous media, and modified to approximate changes 
in field shape and media.  Predicting dose becomes difficult with complex treatment 
geometries such as beam obliquity, small field sizes and tissue inhomogeneities. In 
these complex patient geometries, the Monte Carlo method is known to be the most 
accurate to calculate dose distributions. Recently an electron Monte Carlo (eMC) 
dose calculation algorithm has been incorporated in XiO treatment planning systems 
(Elekta/CMS XiO). This algorithm is based on the Voxel Monte Carlo (VMC) code 
which allows fast dose calculations in voxelised heterogeneous media. This study 
aims to evaluate XiO eMC’s capability to accurately predict dose distribution. 
Simulations with the eMC module were performed for 6, 12 and 18 MeV beams in 
different beam setups. In addition to standard large uniform fields, the effects of 
oblique incidence, small field size and inhomogeneous media were investigated in 
this thesis. A new measuring method was developed for high resolution, absolute 
dose measurement of these non-standard irradiations using radiochromic film. A 
portable holder was designed and constructed to hold films vertically in a 
reproducible setup submerged in a water phantom. The film measurements were 
performed and compared to the calculated XiO eMC 2D dose distributions using the 
gamma dose analysis and distance-to-agreement tool from the SNC Patient software 
(Sun Nuclear Corporation, Melbourne, FL). All 2D comparisons of film and XiO eMC 
were done by comparing absolute dose per monitor unit (MU). The experimental 
film method was verified with ionisation chamber measurements and the total 
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uncertainty for the film measurement method was determined to be ±3% (2σ). In 
water beyond Dmax, XiO electron Monte Carlo and EBT3 film agree to within the 
measurement uncertainties i.e. ± 3% or ± 2 mm  for all standard, oblique and circular 
fields for measurements. Differences between XiO eMC and EBT3 film of up to 9% 
occur close to the surface for the oblique and circular fields. For the inhomogeneous 
media, agreement between XiO and film was also within the calculation and 
measurement uncertainties in the water and lung like regions. Within the rib 
phantom, XiO was up to 10% higher than film. By comparison, agreement between 
XiO and film within the denser skull phantom is within the uncertainties. This 
method has extended the standard set of commissioning measurements to include 
clinically relevant conditions that focus on specific geometries that are difficult or 
impossible to measure using ionisation chambers. Radiochromic film in water proved 
to be a convenient high spatial resolution method to verify electron dose distribution 
in non-standard conditions including inhomogeneous media. 
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INTRODUCTION 
Treatment planning system (TPS) commissioning and validation is generally 
performed with ionisation chambers for standard geometry fields. However, an 
ionisation chamber becomes problematic when measuring complex geometries such 
as beam obliquity, small field sizes and tissue inhomogeneities. In these complex 
geometries, the Monte Carlo method is known to be the most accurate to calculate 
dose distributions. With the introduction of Monte Carlo being implemented in 
commercial treatment planning systems, the need to validate beam models after 
commissioning becomes essential. No single detector type is ideal for these 
measurements where both absolute dose and dose distributions can be determined 
at the same time. The purpose of this study is to evaluate the capacity of the TPS to 
accurately predict dose distributions in challenging complex treatment geometries. 
This work focuses on measurements in clinically relevant conditions that are not part 
of the standard commissioning measurements. The proposed method is using 
radiochromic film in water to provide full scatter conditions. A film holder was 
designed to accurately hold the film vertically below the water surface for 
reproducible set-up. The measurements are aimed at validating the planning system 
by direct 2D comparison for complex geometries including inhomogeneities such as 
lung and bone. This project will provide a better understanding of the ability of 
advanced Monte Carlo calculations to predict dose in complex radiotherapy 
treatment scenarios and give reassurance of dose predictions in these treatments.  
 
1.1 Radiation Therapy 
Radiotherapy is a type of cancer treatment to suppress tumour growth by employing 
ionising radiation. The main objective is to destroy tumour cells while sparing 
surrounding healthy tissue. The principle methods for administering radiotherapy 
are by external beam therapy and sealed-source therapy which is also known as 
Brachytherapy. External beam radiation is the most common form of radiotherapy 
and uses ionising radiation such as photon and electron beams (Williams and 
Thwaites, 2000). A linear accelerator is generally used to produce high energy 
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megavoltage X-rays and electron beams. Gamma-rays from a cobalt unit and low 
energy X-rays from a superficial machine may also be used in radiotherapy. 
Megavoltage X-rays can deeply penetrate tissues and are used to irradiate deep 
seated tumours. By combining multiple beam configuration and orientation, dose 
conformity within the tumour can be achieved.  
Megavoltage electron beams on the other hand, can be used to treat relatively 
superficial tumours of less than 5 cm depth such as skin, scalp, chest walls, breast, 
and nodal boost (Podgorsak, 2010). Electron beams strongly interact with the 
medium they traverse, resulting in a shallow penetration depth, a steep dose fall-off 
and a high surface dose of between 75% to 95% of maximum dose (Khan, 2003). The 
depth dose of an electron beam has a short build-up region which reaches maximum 
at depth depending on energy and then the dose drops off steeply with increasing 
depth as illustrated in Figure 1.1.  
 
Figure 1.1 Relative depth dose curves for megavoltage electron beams over a range 
of energies. Figure reproduced from (Podgorsak, 2005). 
 
1.2 Radiotherapy Treatment Process 
Patients that require radiation therapy are prescribed a dose based on the type and 
stage of cancer. After diagnosis, a computed tomography (CT) scan is acquired to 
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locate the tumour. The CT slices generated from the scan will then be used in the 
treatment planning stage to generate a 3D model of the patient. A radiotherapy plan 
consists of the treatment technique, beam energy, number of fractions and duration 
of treatment. The treatment technique includes the planning target volume with 
beam weightings assigned to each of the beams. Surrounding organs at risk will also 
be taken into account by limiting the dose to these structures. A treatment planning 
system (TPS) calculates dose based on the Hounsfield unit or electron densities of 
materials that are predominant in radiotherapy such as tissue, bone, and muscle. 
The treatment plan will be optimised to conform around the target volume and the 
calculated dose distribution is displayed in a 3-dimensional reconstructed space.  
After the planning stage, the treatment delivery accuracy needs to be verified. 
The delivery accuracy is divided into dosimetric and geometric accuracy. The 
accuracy of the calculated dose when compared to the beam delivery is known as 
the dosimetric accuracy. Geometric accuracy relates to patient positioning and 
immobilisation during treatment. A key component of the delivery of radiation 
therapy is the independent confirmation to ensure correct and accurate dose 
delivery (Stern et al., 2011). The monitor unit (MU) setting determines the quantity 
of radiation delivered to the patient. A monitor unit validation program is generally 
used as an independent check to verify the MU generated from the TPS.  For more 
complex cases such as Intensity Modulated Radiation Therapy (IMRT) or Volumetric 
Modulated Arc Therapy (VMAT), an independent quality assurance process that 
usually involves calculating and delivering the dose to a phantom or a 3D measuring 
device should be implemented. 
During treatment, imaging aids such as Electronic Portal Imaging device (EPID) 
which uses the primary megavoltage beam or On-Board Imager (OBI) which has its 
own separate kilo-voltage source attached to the linear accelerator, are used to take 
images for validation and reproducibility of the treatment setup. 
 
1.3 Treatment Planning Systems 
In the radiotherapy process, TPS plays an important role in simulating dose 
distributions in a patient that would be delivered by the treatment machine. 
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Theoretical models of electron beams and the physics of beam interactions with 
matter are the basis of a TPS. The TPS uses analytical models to predict dose 
distributions using algorithms. Algorithms such as pencil beam (Cygler et al., 1987; 
Hogstrom, 1985; Shiu and Hogstrom, 1991) and electron Monte Carlo (Ding et al., 
2006; Kawrakow et al., 1996; Ma et al., 2002; Ma et al., 1999) are generally used to 
calculate electron dose distributions. 
The Pencil Beam algorithm developed by Hogstrom et.al. (Hogstrom, 1985) has 
been the most common analytical model used for calculating dose distributions. 
Until recently, in the Pencil Beam algorithm, the dose distribution is modelled from a 
collection of forward-directed pencil beam shaped distributions. Due to its simplistic 
dose calculation algorithm, the kernels are scaled only in the depth direction as the 
beam travels through regions with different densities. This is valid if the medium 
consists of water or tissue equivalent densities. Due to the simplifications and 
approximations used in Pencil Beam algorithm, greater errors are expected in the 
presence of inhomogeneous media.  
Monte Carlo (MC) modelling is considered to be the most accurate approach to 
modelling the electron beams interacting with matter (Andreo, 1991; Rogers, 1991). 
This method works on statistical probabilities and models a very large number of 
particles moving through matter. However, in the past, Monte Carlo was restricted 
by computational power. MC is made available and commercialised today due to the 
advancement in computer technology, as well as improvements in the 
implementation of the MC dose calculation algorithms.  
 
1.4 Current Limitations 
Electron radiotherapy is an important modality for cancer treatment. However, 
electron beams continuously lose energy as they penetrate tissue and as such 
change their interaction properties with matter. The primary interactions for 
electrons in the energy range below 50 MeV are collisions with bound atomic 
electrons, bremsstrahlung or radiative losses and elastic scattering. The 
consequences of these interactions are energy loss, change in direction and transfer 
of energy to matter which results in energy absorption and dose deposition. Due to 
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lateral scatter approximations, this has caused difficulty in predicting dose 
distributions using conventional dose calculation algorithms (Hogstrom et al., 1981). 
Large discrepancies of 10% or more have been observed between the Pencil Beam 
dose calculation algorithm and measurements in inhomogeneous phantoms (Cygler 
et al., 1987). This is due to the inappropriate treatment of electron transport in 
inhomogeneous media such as air cavities and bone. The need for accurate dose 
calculation is crucial to improve the calculated dose distributions in treatment 
planning systems. In complex patient geometries, the Monte Carlo method is 
considered to be the most accurate approach for electron dose calculations under all 
circumstances (Andreo, 1991). Monte Carlo simulation can model electron scattering 
in inhomogeneous medium more accurately than any analytical dose models (Jiang 
et al., 2000).  
Our institution recently purchased a commercial electron Monte Carlo (eMC) 
treatment planning system (Elekta/CMS XiO). The XiO eMC algorithm is based on the 
Voxel Monte Carlo (VMC) model which was modified to accommodate vendor 
specific features (Kawrakow et al., 1996). The commissioning procedure for a Monte 
Carlo treatment planning system can be divided into two components; beam data 
acquisition for beam modelling and the validation of the calculated dose 
distributions. Measured data such as depth doses, profiles and output factors will be 
needed to create the beam model. The beam models created for XiO eMC are 
exclusive to the linear accelerator that is being modelled. There are several reports 
recommending the scope and content of commissioning and quality assurance for 
clinical radiotherapy treatment planning systems (Fraass et al., 1998; IAEA, 2004; 
Mayles et al., 1999). For clinical electron beam dosimetry, it is recommended that 
beam data measurements are done using cylindrical and plane-parallel ion chambers 
in a water, or water equivalent phantom (Gerbi et al., 2009).These ionisation 
chambers require ionisation-to-dose conversion factors such as stopping-power 
ratios and perturbation factors to determine the dose. One disadvantage is that 
these conversion factors depend strongly upon electron energy and depth in 
phantom. This is due to the changes in energy spectra at various depths and the 
strong energy dependence of the water to air stopping power ratios. The ionisation-
to-dose conversion factors inherently introduce uncertainty in the absorbed dose. 
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Other disadvantages of using ionisation chambers in electron beams include the lack 
of absorbed dose-to-water calibration factor by the national standards laboratory, 
the difficulty in water proofing the chamber and eliminating the impact of water 
pressure on the thin window of plane-parallel chambers. 
Patient dose distributions can also differ significantly to those in a flat water 
phantom due mainly to the effects of oblique incidence, small fields and tissue 
heterogeneities. Basic electron beam data acquired for the treatment planning 
systems are applicable to normally incident beams on water or water equivalent 
homogeneous media. In reality, real patients have curved surfaces and are not very 
homogeneous. These factors influence the changes in electron scattering, beam 
penetration and interface effects (Khan et al., 1991). As a result, the treatment 
planning system does not provide an accurate representation of the calculated dose 
distributions. 
 
1.5 Thesis Objective 
The need to validate the electron Monte Carlo dose calculations in conditions other 
than the standard measurements for normally incident beam and homogeneous 
media remains a challenging task to perform. Despite the difficulties, ionisation 
chambers are recommended for dose measurement because they are portable, easy 
to use and highly reproducible (Khan et al., 1991). However, for measurements of 
non-standard fields, ionisation chambers can be problematic. In regions with large 
dose gradients, spatial resolution is limited by the physical size of the ionisation 
cavity. For small field sizes, the lack of charged particle equilibrium becomes an issue 
because Bragg-Gray cavity theory conditions are not valid and therefore the 
interpretation of ionisation chamber output in terms of dose is difficult. The aim of 
the study is to develop radiochromic film as an alternative to ionisation chambers for 
high resolution measurement of dose for non-standard beam geometries. The focus 
is to extend the standard set of treatment planning system commissioning 
measurements to include clinically relevant conditions. A procedure for interpreting 
the results was developed to analyse and compare depth dose profiles and 2-D dose 
distributions between eMC calculations and film measurements. 
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BACKGROUND 
This chapter mainly focuses on the theoretical foundation of electron interactions 
and properties in radiation therapy, the Monte Carlo dose calculation algorithm, and 
radiochromic film. The justification of the project and experimental approach is also 
discussed with a brief review of the most relevant references or journal articles.   
 
2.1 Electron interactions with matter 
When an electron traverses matter, it interacts with the atomic orbital electrons and 
nuclei by Coulomb interactions which will result in energy loss and scattering. The 
important interactions between electrons and matter are: 
a) Inelastic collisions with orbital electrons (ionisation or excitations) 
b) Inelastic collisions with nuclei (Bremsstrahlung) 
c) Elastic collisions with orbital electrons (Coulomb scattering) 
d) Elastic collisions with nuclei 
Energy losses from inelastic electron interactions can be classified into two 
processes; collisional and radiative losses. Collisional losses involve interactions with 
orbital electron and a radiative loss results from interactions with atomic nuclei as 
illustrated in figure 2.1.  When an incident electron collides with an orbital electron, 
ionisation or excitation happens. When ionisation happens, the orbital electron is 
ejected from the absorber atom creating an ion pair (Podgorsak, 2005). Each time 
the incident electron ionises an atom, it loses a small amount of energy. However, if 
the energy is not sufficient to eject an electron from the atom, it is used to raise the 
orbital electron to a higher-energy state (Khan, 2010). This process is termed 
excitation. Both excitations and ionisations are part of collisional energy loss.  
Radiative losses occur when an incident electron interacts with the nucleus of 
the absorber atom. The electron would scatter and changes trajectory with a loss in 
energy. This energy loss is emitted as a photon known as Bremsstrahlung. 
Occasionally, the passing electron may cause an electron to be ejected from a shell 
resulting in characteristic X-rays being emitted when an outer shell electron takes its 
place. 
21 
 
 
Figure 2.1 Electron interaction process a) excitation, b) ionisation, c) Bremsstrahlung 
production and d) characteristic radiation. Figure reproduced from (Klevenhagen, 
1993). 
  
Elastic collisions are interactions that result in no energy transfer from the 
incident electron to the orbital electron. The trajectory of the electron is altered by 
the presence of the orbital electron without the loss of kinetic energy. If the incident 
electron undergoes an elastic collision with a nucleus, the electron will be deflected 
towards the nucleus. In the case of an elastic interaction with an orbital electron, the 
incident electron will be deflected away from the orbital electron. Figure 2.2 shows 
the interactions between an electron and the nucleus of the absorber medium. 
 While photon interacts with matter via photoelectric, Compton and pair 
production processes, charged particle interact by direct ionisation. This occurs if the 
charged particles have sufficient kinetic energy to produce ionisation as they 
traverse through matter (Khan, 2010). As the incident electron penetrates through 
the medium, the energy is lost along the ionisation track. Occasionally, during the 
interaction process, the ejected electron contains sufficient energy to produce a 
secondary ionisation track of its own (Khan, 2010). This is also known as a δ ray. As 
the electrons travel deeper in the medium, the energy is degraded until they reach 
thermal energies and are then captured by the surrounding atoms (Khan, 2010). 
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Figure 2.2 Elastic collisions resulting in electrons being deflected from its initial 
trajectory. Figure reproduced from (Krumeich, 2015). 
 
2.2 Radiotherapy with electron beams 
Electron beams that are used clinically are produced from a linear accelerator that 
uses high frequency electromagnetic waves to accelerate electrons to higher 
energies. Electrons generated from an electron gun are injected into a waveguide 
which consists of a series of microwave cavities. Microwaves that are fed into the 
cavities are generated by a klystron. As the electrons travel through the waveguide, 
electrons gain energy as they are accelerated through each cavity due to its electric 
field. As a result, a pencil beam of about 3mm wide exits the waveguide. 
Most modern linear accelerators use a bending magnet to ensure that the 
beam is mono-energetic. A 270 degree bending magnet is generally used to refocus 
all the electrons to a desired position to maintain a small virtual spot size. An energy 
slit embedded in the bending magnet is designed to remove electrons that are not 
within 3% of the nominal peak of the selected electron energy (Zhang et al., 2009). 
On exiting the bending magnet, the electron beam then strikes an electron scattering 
foil which spreads the beam and produces uniform electron fluence. After being 
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scattered by the scattering foil, the beam passes through a monitor chamber which 
is responsible for monitoring dose rate and beam flatness (Podgorsak, 2005). The 
electron beam then needs to be collimated multiple times before achieving a flat and 
symmetrical beam with a well-defined penumbra. It is necessary to further collimate 
the electron beam beyond the secondary collimators because electrons will increase 
in angular spread due to scatter as they traverse through air. This is done by 
attaching an electron applicator together with a shaping aperture at the end. A cross 
section of the treatment head is shown in figure 2.3.  
 
 
Figure 2.3 Schematic of a linear accelerator treatment head in electron mode. 
Figure reproduced from (Khan, 2003). 
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2.3 Electron beam properties 
2.3.1 Variation of dose with depth 
Electron beams have characteristic variations of dose with depth in water. This is 
also known as the depth dose curve which is shown in figure 2.4. All beam energies 
display a similar feature, starting with a dose build up to maximum dose followed by 
a rapid drop off until it levels off at a low dose which is called the Bremsstrahlung tail 
(Podgorsak, 2005). As the energy increases, the curve extends further into the 
medium but the gradient of the drop off is not as steep as the lower energies. This is 
due to the scattering power being greater at lower energies and at higher beam 
energies will be less scattered and more forward directed. To characterise an 
electron beam, the dose parameters used are surface dose, depth of dose maximum 
(Dmax), R90 and R80 which are depths in water at 90% and 80% of the dose maximum, 
R50 which is also used to define the beam quality, practical range (Rp) and the 
Bremmstrahlung tail which is the X-ray component of the beam. Figure 2.5 illustrates 
the definition of the parameters. R90, the depth of the 90% dose is also known as the 
therapeutic range is the most useful treatment depth clinically as dose is often 
prescribed to that isodose line. Energy choice for electron beams is critical in 
treatment planning. The dose decreases rapidly beyond the 90% dose level. R50, the 
depth at 50% dose level is used as a measure of the beam’s quality index (IAEA, 
2000). 
 
Figure 2.4 Percentage depth dose for electron energy ranging from 6-18 MeV in 
water at SSD of 100 cm in a 10x10 cm
2
 applicator.  
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Figure 2.5 Characteristic parameters of the percentage depth dose in water. 
 
2.3.2 Beam energy 
Electron beam energy varies as a function of depth. Due to the complexity of the 
energy spectrum, there is no single energy parameter that will characterise an 
electron beam. There are several parameters used to describe an electron beam, 
such as the most probable energy (Ep,0) on the phantom surface, the mean energy 
(Ē0), and R50. The most probable energy is related to the practical range (Rp) and its 
described by the relationship (Paul et al., 1985) 
 ,  0.22 	 1.98 	 0.0025	 2.1 
 
As recommended by TG-21 protocol (Paul et al., 1985), the mean energy (Ē0) is 
related to R50 and is described as 
 Ē  2.33 2.2 
 
The mean energy and most probable energy of electrons at a phantom surface 
are generally used to determine energy dependent parameters such as the stopping-
power ratios and the electron fluence correction factors. 
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2.3.3 Dose in build-up region 
Electrons are scattered easily with larger angles at lower energies which causes dose 
build-up to be rapid over short distances (Khan, 2010). The surface doses for 
electron beams are typically 80 to 90% of Dmax dose and increases with increasing 
electron energy. This differs from photon beams where surface dose decreases with 
increasing energy and is typically 20% to 30% of Dmax dose.   
 
2.3.4 Bremsstrahlung contamination 
The dose distribution beyond Dmax has a sharp drop-off and it is due to scattering and 
continuous energy loss. The low dose tail of the depth dose curve is attributed to 
Bremsstrahlung produced in the head of the accelerator, in air between the 
accelerator head and the patient, and in the irradiated medium. The Bremsstrahlung 
contamination increases with increasing electron energy and is typically in the range 
of 0.5% to 4%.  
 
2.3.5 Effective source position 
Unlike photon beams where the source position is located at the X-ray target, 
electron beams generated from a linear accelerator appear to originate from an 
effective source located close to the scattering foils. The location of the effective 
source is known as the effective, or virtual, source position. The distance between 
the isocentre of the linear accelerator to the effective source position is known as 
the effective source-to-surface distance (SSDeff). The position of the effective source 
determined geometrically will differ from the position derived dosimetrically. There 
are various methods to determine SSDeff. The commonly used method to derive 
SSDeff dosimetrically is to measure dose at various distances from the electron 
applicator by varying the gap between the phantom surface and the applicator 
(Podgorsak, 2005).  
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2.3.6 Field size 
To determine the radiation width of a beam profile, RW50 (Figure 2.6), defined as the 
width of the profile at half its maximum intensity compared to the intensity value at 
the beam axis (NCS, 1996), is used. 
The field size dependence of the depth dose curve is very low if the field size is 
large enough to provide lateral scatter equilibrium. However, when the field size 
decreases to less than the lateral range of secondary scattered electrons, the shape 
of the depth dose curve is altered. As the field size decreases, the dose gradient is 
less steep and the depth of Dmax shifts towards the surface (Khan, 2010). Figure 2.7 
shows the variation of the depth dose curve with varying field diameter. Therefore, 
as a general rule of thumb, the minimum electron field size for lateral scatter 
equilibrium at central axis is approximated to be E (MeV)/2.5 (cm). For irregular field 
sizes, the depth dose curve is shown to be very similar to equivalent circular field 
sizes (Khan, 2003). 
 
 
Figure 2.6 Radiation width (RW50) of a beam profile defined at the 50% of the 
central axis dose. Figure reproduced from (NCS, 1996). 
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Figure 2.7 Depth dose curve variation with field size for 8 and 32 MeV electron 
beams. Figure reproduced from (ICRU, 1984a). 
 
2.3.7 Oblique incidence 
Angle of incidence of the incident electron beam alters the depth dose curves. This 
occurs when the treatment applicator is not parallel to the skin surface. As the angle 
of incidence increases, the slope of the dose gradient and the depth of maximum 
dose decrease. The effect of oblique incidence is represented by a number of pencil 
beams incident on an angled surface with each beam overlapping with the adjacent 
beam. Due to the overlap, the side scatter closer towards the surface increases and 
therefore increasing dose near the surface. A higher surface dose is observed for 
lower energy beams while higher energy beams show a slight increase in surface 
dose (Khan et al., 1985; Ulin and Sternick, 1989). This effect is illustrated in figure 
2.8. The position and gradient of the depth dose curve is also affected by obliquely 
angled electron beams. It has been shown that oblique incidence tends to shift the 
position of Dmax toward the surface which decreases the penetration depth (Ekstrand 
and Dixon, 1982) and at oblique angles greater than 30°, the gradient of the curve 
decreases.  These effects are shown in figure 2.9.  
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Figure 2.8 Illustration of how oblique incident surface angle impacts electron 
beams. Figure reproduced from (Khan, 2010). 
 
 
Figure 2.9 Changes in depth dose curve with oblique surface angle for a 9 MeV 
electron beam. Figure reproduced from (Khan, 2010).  
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2.3.8 Inhomogeneities 
Electron beam dose distribution can be altered in the presence of tissue 
imhomogeneities such as bone and lung. With the presence of these 
inhomogeneities, there will be changes in scattering effects, especially at the 
interface between different media. This is known as interface effects. When the 
electron beam strikes the interface between the two materials, the scatter 
perturbation will affect the dose distribution near the interface. The lower density 
material will receive higher dose due to increased penetration of electrons. This 
effect can be seen in Figure 2.10. Within the low density region, electrons travel 
further with fewer scattering events. Hence the depth dose curve does not drop off 
as steeply in lung when compared to water.  
 
 
Figure 2.10 Depth dose effect of a 5cm lung inhomogeneity on a 15 MeV electron 
beam. Figure reproduced from (Podgorsak, 2005). 
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2.4 Monte Carlo techniques for electron beam radiotherapy 
treatment planning 
2.4.1 Treatment planning dose calculation algorithms 
Treatment planning systems (TPS) are used to simulate dose distributions for a 
radiotherapy prescription. TPSs utilise dose calculation algorithms to predict the 
dosimetry in a patient. The Pencil Beam algorithm is one of the most commonly used 
analytical models in radiotherapy dose calculation programs (Hogstrom et al., 1981). 
Pencil beam algorithms are accurate in predicting dose distribution in situations 
where the geometry is a homogeneous material or infinite heterogeneous slabs 
normal to the incident beam. When three dimensional inhomogeneities are 
introduced to the calculations, the dose distribution was reported to have 
discrepancies of up to 12% (Mah et al., 1989). The reason for the lack of accuracy is 
that pencil beam algorithms do not take changes in lateral scatter into account when 
inhomogeneities are encountered. Improvements  have been made in recent years 
but the gain in accuracy remains limited (Kawrakow et al., 1996).  
Monte Carlo based algorithms have the highest accuracy among electron beam 
algorithms (Doucet et al., 2003). Full Monte Carlo algorithms are capable of 
simulating every particle interaction in a given volume. They are used to model the 
effect of each individual event in the transport of radiation through matter (Bielajew 
and Rogers, 1992). However, this requires an enormous amount of processing power 
and time. To implement Monte Carlo algorithms in a commercial treatment planning 
system, a compromise between accuracy and calculation time has to be made. With 
recent developments to computer hardware, it is now possible to run fast Monte 
Carlo codes in a reasonable amount of time, generally of the order of a few minutes 
to under an hour (Ma et al., 2002). However, due to the enormous number of 
particles that have to be simulated, the computation time can be excessive 
regardless of hardware advances. To significantly decrease computation time, 
approximations and simplifications of the transport processes are made to the 
algorithm whilst maintaining a high degree of accuracy. Several fast Monte Carlo 
codes have been developed to improve efficiency and decrease the calculation time, 
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such as Macro Monte Carlo (Neuenschwander et al., 1995), Superposition Monte 
Carlo (Keall and Hoban, 1996) and Voxel Monte Carlo (Kawrakow et al., 1996). The 
Macro Monte Carlo code is implemented in the Eclipse Treatment planning system 
and Voxel Monte Carlo code is implemented in XiO. Only XiO’s Voxel Monte Carlo is 
the subject of this investigation and therefore is discussed in detail here. 
 
2.4.2 Voxel Monte Carlo for electron beams 
Monte Carlo models like EGS4 (Nelson et al., 1985) and ETRAN (Seltzer, 1988) are 
designed to perform full simulations of electron transport in materials for a wide 
range of energies. The time required to calculate can make it difficult to use these 
codes in radiation therapy. Voxel Monte Carlo (VMC) (Kawrakow et al., 1996) was 
developed by introducing simplifications and approximations to the transport 
algorithm that are applicable in the kinetic energy range from 1 to 30 MeV, i.e. the 
radiation therapy range. 
The basis of the Voxel Monte Carlo algorithm for electron beams starts off with 
the trace of one electron interaction history, simulated in homogeneous water using 
multiple elastic and inelastic scattering (Kawrakow, 1997). The particle is scattered 
due to the collisions it undergoes and loses energy in inelastic collisions. The 
algorithm uses a simplified probability distribution function for multiple scatter 
which is a function of scattering power and electron momentum (Kawrakow et al., 
1996). The simplified form of the multiple scattering distribution used by the model 
results in an underestimation of large angle scatter. This was assumed to be 
insignificant for beam geometries studied in the original work (Kawrakow et al., 
1996) which were all normally incident on the phantom. The secondary electron 
production is also simplified and is described using Møller differential cross section 
(Kawrakow et al., 1996). The code approximates the sampling of secondary electron 
energy and is done using a cut off energy (EC) (Kawrakow et al., 1996). For a given 
calculation voxel size, the production of secondary electrons are negligible due to 
the short travel range. Therefore, below this cut off energy, there is no secondary 
electron production and the incident electrons lose energy in a continuous process. 
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To improve calculation times, bremsstrahlung produced in the model is 
immediately discarded. To account for the bremsstrahlung photons generated from 
electron interactions, a photon background dose taken from the measured dose 
distribution in a water phantom is added to the calculated dose distribution 
(Kawrakow et al., 1996). The background photon dose can originate from two 
sources; the bremsstrahlung photons produced in the patient and contamination 
photons escaping the head of the linear accelerator. The bremsstrahlung photons 
produced in the patient are a product of inelastic collisions with nuclei which leads to 
radiative losses. The photons generated from the head of the linear accelerator are a 
result of the electron beam interacting with components such as the transmission 
monitor chamber, scattering foil, collimators and electron applicator.  
The continuous energy loss of electrons is simulated by modifying the mass 
stopping powers provided by the ICRU (ICRU, 1992). These stopping powers include 
both energy losses due to discrete interactions and energy loss due to continuous 
processes. The continuous process is the energy loss due to inelastic process where 
particles with energies below the applied cut off energy are produced (Kawrakow et 
al., 1996). To obtain the continuous radiation, the stopping power due to 
interactions is subtracted.  
VMC uses history repetition to reduce the number of histories simulated 
(Fippel, 1999). If two electrons are incident on a homogeneous phantom, the same 
electron histories are simulated varying only in the initial position and direction 
(Kawrakow et al., 1996). VMC uses pre-calculated electron history in a water 
phantom and applies the history to the existing patient geometry. The electron path 
lengths and scattering angles in heterogeneous medium is rescaled and adjusted 
based on the total stopping power of the medium.  
XiO treatment planning system (Elekta) adopted the VMC model and modified 
it to accommodate vendor specific features (Kawrakow et al., 1996). XiO electron 
Monte Carlo (eMC) has eight user-definable parameters for calculations: maximum 
number of histories, goal mean relative statistical uncertainty (MRSU) and MRSU 
threshold, dose update interval, random number generator seed, calculation grid 
size, heterogeneity correction and calculation of dose to medium or dose to water. 
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The description of these parameters were based on the XiO User Training Guide 
(ELEKTA, 2010). 
 
2.4.3 Beam Modelling 
The XiO eMC source model and algorithm is based on an early version of XVMC 
(Fippel, 1999). The description of the source model and algorithm used by XiO eMC 
to simulate the transport of electrons through air is well described by Vandervoort et 
al.  (Vandervoort et al., 2014) as summarised below.  
To perform Monte Carlo treatment planning, each linear accelerator beam is 
modelled as a combination of photon and electron sources specific to the applicator 
and energy combination. The primary electron source uses an energy spectrum 
based on the Landau distribution (Landau, 1944) and particle transport begins in a 
plane below the jaws. In the same plane, particle transport for the photon 
contamination source also begins. By sampling points from a source distribution 
above the start plane, the initial position and direction of particles are determined. 
The off-axis particle fluence distribution is modelled by multiplying a radially 
dependent factor to the particle weight. The particle direction is modified by a 
scattering angle from an energy dependent Gaussian distribution. To transport 
electrons through the applicator, simplified air scatter logic is used to change 
direction at every step. With this process, it is assumed that there is no energy loss 
or creation of secondary particles. Between the end of the applicator and the patient 
surface, the step size is a tuneable parameter for different SSDs. Highly scattered 
electrons are excluded in this region because they are unlikely to contribute to 
patient dose (ICRU, 1984a). From the top plane of the electron cut-out, an additional 
electron source is employed to compensate for the approximations in electron 
transport through the air column. This source is the primary tuneable parameter for 
adjusting applicator output factors during beam modelling to match measurement. 
To correct for missing surface dose, another source of highly scattered low-energy 
electrons is also available if necessary. XVMC is not designed for use with high-Z 
materials hence particle transport through the accelerator head is not modelled 
explicitly. Particle interactions with applicator cut-outs are modelled using kernels 
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precomputed with EGSnrc (Kawrakow et al., 2002). “Transmission kernels” are used 
to model particles incident on the top surface of the cut-out outside the aperture. 
“Rim kernels” model electrons incident on top the surface of the cut-out within 0.5 
cm of the aperture. Finally, “face kernels” model electron scatter off the interior 
faces of an aperture. For patient specific cut-outs, the material composition, 
thickness, distance from the nominal source position of the accelerator to lower 
surface of the cut-out must be provided (Edimo et al., 2013). 
The beam model provides information about the location, direction and energy 
of incident particles to the patient dose calculation algorithm and is machine 
specific. This is simplified by using measured data to determine the fluence 
distributions (Chetty et al., 2007). A set of measured depth doses, axial and 
transverse profiles and output factors is acquired and the model parameters are 
adjusted by the manufacturer (ELEKTA) to minimise the difference between 
measurements and calculations in water. The depth dose curves are used to 
determine the energy spectrum of the beams and the off-axis variations are 
accounted for by the lateral profiles. The output factors are used to determine the 
amount of scatter from the applicator, cut-out and air column in the beam. The 
quality of the beam model is highly dependent on the quality of measurements. 
Advantages of using measurement-driven models are that they do not require 
data of the linear accelerator head which helps by saving calculation time and disk 
space (Ma et al., 1997). The beam model is divided into two parts; particle transport 
though the linear accelerator head and dose calculation in the patient. The particle 
transport involves Monte Carlo simulation of the accelerator head where beam 
simulations are based on the interactions of electrons in the linear accelerator head. 
Elekta models the accelerator head using calculation kernels which takes care of 
electron transport before the patient. These calculation kernels are full Monte Carlo 
simulations of the linear accelerator and applicator combinations which are 
performed beforehand and saved to storage. This provides individual beam models 
for each energy and applicator. The VMC code starts its calculation only when the 
beam enters the patient. 
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2.4.4 Maximum Number of Histories 
One particle history of a calculation is the possible path length or the sequence of 
interactions that could occur until the particle has lost all its energy. Each sequence 
of energy loss and secondary particle creation is simulated from the primary particle. 
Once the maximum number of histories is reached, the simulation process will 
terminate. The maximum number of histories is defaulted to 1.0E+12. By increasing 
the number of histories, the statistical uncertainty will reduce but the computational 
time increases. To determine an acceptable isodose distribution, a certain minimum 
number of histories are required. However, adding extra histories does not 
necessarily improve the accuracy of the dose distribution, only the statistical 
uncertainty. For that particular reason, the number of histories was set to the default 
and the goal mean relative statistical uncertainty parameter was used to terminate 
the calculation.  
 
2.4.5 Goal Mean relative statistical uncertainty (MRSU) and MRSU 
Threshold 
The goal MRSU is a parameter used to terminate the calculation. The goal MRSU 
value fixes the largest average uncertainty that is accepted in the final dose 
calculation and has an allowable range of 0 to 100%. Typically XiO runs 1.0E+8 
histories to reach a goal MRSU of 2%. To allow XiO to simulate the maximum number 
of histories, i.e. 1.0E+12, the goal MRSU must be set to zero. The particle histories 
will continue to be generated until the goal MRSU parameter is reached. The goal 
MRSU parameter is defined as: 
 
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Where, D is the dose, P is the threshold percentage dose set by the user, N is the 
number of voxels where dose is greater than or equal to P,  !" is the estimated 
variance of the mean at voxel k and #" is the squared dose deposited in voxel k. The 
MRSU threshold, P is used to control the voxels that will be included in the MRSU 
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goal calculations. The MRSU threshold sets the limit to account for dose deposited in 
the entire computation grid. Not every voxel needs to enter in the calculation of this 
average. If 50% was chosen for the threshold, voxels where the dose is less than half 
of the maximum dose deposited will not be included. The sum is computed over the 
N voxels that satisfy the condition hence saving calculation time. 50% is the default 
value for P because this allow comparison with the ICCR 2000 benchmark of Monte 
Carlo codes (Rogers and Mohan, 2000). 
Using a small goal MRSU value such as 0.5% or 1% will typically require a large 
number of histories and would increase the calculation time. The calculation time 
can be reduced by increasing the goal MRSU. In a clinical environment, a goal MRSU 
between the range of 1% and 2% is generally acceptable because the balance 
between calculation time and the variance needs to be met for practical use in a 
clinical scenario. Decreasing the goal MRSU only means reducing the statistical 
uncertainty in a voxel. Users need to aware of the statistical variation of individual 
points that may have dose uncertainties higher than the average. When a dose 
calculation is performed, there will always be a chance that the computed dose in a 
particular voxel could be higher or lower than the average dose. To avoid 
signification errors, dose should be prescribed to a volume rather than to a single 
point.  
 
2.4.6 Dose Interval Update 
The maximum number of histories and Goal MRSU setting are used to determine 
when to stop the dose calculation. These parameters are not constantly being 
checked. Dose update interval allows the user to set the number of histories after 
which the dose distribution is evaluated and updated graphically. This parameter is 
mainly to reduce total calculation time by checking that the simulation has achieved 
the termination criteria (goal MRSU) and does not generate unnecessary histories. 
 
2.4.7 Random Number Generator Seed 
In Monte Carlo algorithms, the initial interaction of a particle is determined by 
random numbers. This random number is generated by a separate software program 
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called the Random Number Generator. A seed number is set by the user to 
determine the first number sequence generated by the random number generator. 
The seed will generate a random number sequence and is determined by fixed 
calculation steps. XiO eMC allows the user the set the seed but it will not influence 
the quality of the dose calculation. 
 
2.4.8 Calculation Grid Size 
A grid for an eMC calculation is defined as a cubic volume in the CT reconstructed 
slices of a patient. This volume is then divided into individual voxels with user 
definable dimensions. As the number of voxels in the calculation grid increases, so 
does the calculation time. If the nominal field size increases with a fixed grid size, 
relatively more voxels are being included and therefore increasing the overall 
calculation time. Similarly by increasing the beam energy, the calculation time also 
increases. If the particle is more energetic, the particle will travel deeper with a 
longer track hence increasing the number of included voxels. The impact of grid size 
also affects the statistical uncertainty and dose accuracy. As the grid size increases, 
volume averaging occurs and therefore reduces the accuracy of steep dose 
gradients. If the goal MRSU remains unchanged, then the final uncertainty and 
accuracy of the calculation will remain constant with grid size. 
 
2.4.9 Medium characterisation 
Both the XVMC and VMC electron Monte Carlo codes extract interaction properties 
by directly correlating the collision and radiative stopping powers with the 
Hounsfield Unit (HU). With this method, material properties vary continuously with 
HU and there are no arbitrary boundaries between tissue types based on HU. Nor 
does it require a CT calibration curve (Reynaert et al., 2006). 
However, in XiO eMC the conversion from CT number to material properties is 
done in two stages. Firstly, the CT number is mapped to an electron density table 
specific to the CT scanner. Then the electron density is mapped to mass density using 
an internal conversion table. The XiO eMC dose engine uses the same approach as 
XVMC for the assignment of material properties. The mass density is used to 
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calculate correction factors that modify electron stopping powers, electron 
scattering powers and photon attenuation coefficients that are tabulated for water 
(J. Satterthwaite 2016, personal communication, 19 November). Therefore only data 
for water is used in the XiO eMC calculation. The media composition is only used to 
derive correction factors for the water data. 
  
2.4.10 Heterogeneity Correction 
XiO eMC offers the option of heterogeneity in the dose calculation module. When 
‘Yes’ is selected, the electron density of each voxel is determined using the current 
CT slices. If the option is set to ‘No’, XiO eMC assigns a relative electron density 
equivalent of 1.0 to every voxel within the patient surface instead of the actual 
density from the CT image. The relative electron density is the electron density of 
the material (electrons cm-3) divided by the electron density of water (electrons cm-
3). This option is useful when heterogeneity correction tests are performed as part of 
routine quality assurance checks. 
 
2.4.11 Dose to medium/water calculation 
Absorbed dose can be calculated to water or medium with XiO eMC. In the current 
clinical practice, to compare Monte Carlo simulations of dose-to-medium (Dm) to 
dose-to-water (Dw), a conversion from Dm to Dw is required. Due to this requirement, 
when dose to water is selected, the algorithm will calculate dose to a small mass of 
water within the medium. When dose to medium is selected, the absorbed dose is 
calculated for that medium based on the material composition. The difference 
between dose to water and dose to medium calculations is an important issue. There 
is still debate in the medical physics community about which of these methods is 
most appropriate (Ma and Li, 2011). Due to the difference in calculated dose 
between dose to medium and dose to water, users need be aware of these changes 
as they can directly affect the dose delivered to patients. 
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2.5 XiO eMC algorithm limitations 
Every treatment planning algorithm has its limitations. For XiO eMC (V4.80.03), the 
limitations that are stated in the training guide (ELEKTA, 2010) are summarised in 
this paragraph. The source-to-surface distance (SSD) is limited to the range between 
100 and 115 cm. At SSDs shorter than 100 cm, dose artefacts may appear due to the 
scatter simulation from the electron insert. For SSDs beyond 120 cm, the air scatter 
approximations may create errors. For most clinical cases, the SSD will be within the 
range of 100 cm – 115 cm. Exceptions may occur with oblique incidence or irregular 
surfaces which may result in the SSD being slightly outside this range.  
High density materials in the patient volume maybe significantly decrease the 
dose calculation accuracy. This is due to the simplified approximations that are used 
in the electron transport and the creation of secondary particles. Another limitation 
is known as voxelisation artefacts or partial volume effects. Due to the limited 
resolution of the dose grid, the density within the voxels maybe averaged when it 
lies in the interface between different densities. One major limitation is that 
computed point doses should never be used for Monitor Unit (MU) calculations 
(Chetty et al., 2007). Clinical plans should always be verified by the coverage of 
isodose lines and dose volume histograms (DVH).  XiO calculates MUs based on the 
dose at the beam weight point. This is counter to the recommendations of AAPM 
TG105 report (Chetty et al., 2007). However, the statistical uncertainty at the beam 
weight point is significantly smaller than the overall uncertainty for the beam. This 
means for a goal MRSU of 1 to 2%, the statistical uncertainty for MUs is 
approximately 0.5 to 1%.    
 
2.6 Radiochromic Film (GafChromic®) 
Radiochromic films are dosimeters that depend on the process of permanent 
colouration when exposed to ionising radiation (Niroomand-Rad et al., 1998). 
International Specialty Products (ISP, Wayne, NJ) manufactures a self-developing 
radiochromic film called Gafchromic® EBT. Radiochromic films are based on the 
polymerisation of microcrystals which results in the film progressively changing 
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colour. Its optical density change has a correlation to the amount of absorbed dose. 
Radiochromic films have been widely investigated and it has been shown that the 
response is independent of fractionation, dose rate and energy (Arjomandy et al., 
2010; Su et al., 2007). Depth dose measurements with radiochromic films have also 
been investigated and have proven the films to be an accurate dosimeter 
(Arjomandy et al., 2012; O'Reilly et al., 2013; Xu et al., 2009). 
The first type of Gafchromic® EBT film, released in 2004 was suitable for use 
with radiotherapy doses. In 2009, Gafchromic® EBT film was replaced by 
Gafchromic® EBT2 film that incorporates a yellow marker dye in the active layer 
between the polyester laminate to allow for non-uniformity corrections and protect 
the active layer from exposure by UV and visible light (Casanova Borca et al., 2013; 
Reinhardt et al., 2012). In 2011, ISP released Gafchromic® EBT3 which has significant 
improvements over the predecessor such as identical polyester laminating layers 
giving it a symmetrical composition and a matte polyester substrate layer that 
prevents Newton’s Rings formation. Gafchromic® EBT3 film is comprised of a single 
active layer, 30 µm thick which contains the active layer and marker dye. The active 
layer is between two 125 µm transparent polyester layers which have matte 
surfaces. The purpose of the matte surface is maintain a gap between the film 
surface and the glass window to prevent the formation of Newton’s Rings, or 
interference patterns, when acquiring images using a flatbed scanner. These films 
provide sub millimetre spatial resolution when read-out by commercial flatbed 
scanners and are therefore capable of very high resolution dose measurements. 
Figure 2.11 displays the different layers between EBT, EBT2 and EBT3 film. 
Gafchromic® EBT3, which replaces the previous EBT2, has been shown to have 
similar dosimetric properties (Reinhardt et al., 2012). The symmetrical composition 
completely eliminates the dependence of the response on the direction of exposure 
(Casanova Borca et al., 2013; Reinhardt et al., 2012). Directional response of film has 
been studied (Suchowerska et al., 2001) and the findings are that films has low 
directional response except when irradiating parallel to the central axis if the beam. 
When film is irradiated parallel rather than perpendicular to the beam, an over 
response is seen and it has been suggested that the air gap rather than the 
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orientation of the film that is the cause of the over response (Suchowerska et al., 
2001).  
 
Figure 2.11 Diagram of the Gafchromic® film composition layer for (a) EBT, (b) EBT2 
and (c) EBT3. Figure reproduced from (Devic et al., 2012). 
 
There are several possible sources that can influence the accuracy of 
Gafchromic films when scanned with flatbed scanners. When scanning of irradiated 
EBT3 films are performed, the polarisation of the transmitted light increases with 
increasing dose (Schoenfeld et al., 2014). The magnitude of the artefact is dependent 
on the lateral position of the film on the scan window. There have been a few 
studies proposing the correction of lateral response artefact (Butson et al., 2011; 
Paelinck et al., 2007; Poppinga et al., 2014). The change in response over the lateral 
scan axis was quantified and an increase in dose of up to 14% at maximum lateral 
position was seen (van Battum et al., 2016). The artefact due to the light polarisation 
of film and the scanner’s optical mirror system can be significantly reduced by 
setting lateral limits on the scan window restricting it to the central region. 
Another source of film uncertainty is the uniformity of EBT3 films. It has been 
investigated to show that intra-film uniformity increases with increasing dose and 
was less than 1% for electron beams (Sorriaux et al., 2013). EBT3 film dose response 
for various radiation types, including photons, electrons and protons, were also 
investigated and was shown to have a maximum spread 11.5% at doses from 0 to 10 
Gy and up to 7.1% at 10 Gy (Sorriaux et al., 2013). 
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2.6.1 Dose response curve 
When radiochromic film is exposed to radiation, the discolouration of the film has a 
non-linear relationship to the amount of dose delivered. The discolouration effect 
will have a light attenuating effect which will block visible light from passing through 
the film. This reduction of light through the film is a measure called optical density 
(OD). An exponential function can be used to describe the relationship between the 
dose and OD. Figure 2.12 shows various calibration curves of different energies in a 
dose range of 0-10 Gy for 6 MV and 18 MV photon beams, 60 MeV and 100 MeV 
proton beams and 6 MeV electron beam (Sorriaux et al., 2012). 
 
 
Figure 2.12 Dose VS Optical Density curve for a dose range of 0-10 Gy for 6 and 18 
MV photon beams, 60 and 100 MeV proton beams and 6 MeV electron beam. 
Figure reproduced from (Sorriaux et al., 2012). 
 
Dose response curves are generated by exposing films to different dose levels 
and scanning them on a flat-bed scanner. Several studies have investigated the use 
of commercial flatbed scanners for film dosimetry (Devic et al., 2004; Devic et al., 
2005; Devic et al., 2006) which are shown to be an accurate tool for scanning. Theses 
scanners are generally used in the RGB (Red Green Blue) scanning mode. These 
colour channels exhibit a variation between the calibration curves and it has been 
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shown that the red channel is more appropriate at the therapeutic dose range 
(Sorriaux et al., 2012). 
 
2.7 Rationale for objectives 
Validation of a Monte Carlo treatment planning system should include assessing the 
accuracy of the beam model and the radiation transport algorithm in homogeneous 
and heterogeneous phantoms (Chetty et al., 2007). The beam model validation is to 
ensure parameters of the incident beam energy are correctly configured to produce 
dose distribution that is in agreement with the treatment machines. General 
recommendations are given for tests involving measurements in a homogeneous 
water phantom (Fraass et al., 1998; IAEA, 2004; Van Dyk et al., 1993), but issues 
related to non-standard measurements are excluded. These recommendations are 
generally point dose measurements at various locations within and outside 
heterogeneity regions and are done by positioning measurement devices such as 
ionisation chamber or diodes within the phantom. However, with ionisation 
chambers and diodes, there are disadvantages when using under electronic 
disequilibrium conditions. Measurement uncertainties such as beam quality 
dependence, polarity effects, ion recombination effects, and perturbation effects are 
some of reasons why ionisation chambers and diodes fail to accurately measure non-
standard fields (Chetty et al., 2007; Gerbi et al., 2009).  
AAPM TG-105 strongly encourages that validation testing of the Monte Carlo 
algorithm include experiments emphasising electronic disequilibrium effects (Chetty 
et al., 2007). The use of anthropomorphic phantoms in this case seems feasible for 
the range of clinical circumstances but this method is generally an end-to-end test, 
not a commissioning procedure. An end-to-end test mimics the clinical workflow and 
any discrepancies are a result of the entire process. A commissioning procedure is 
generally a subset of specialised tests that can identify problems individually. The 
current state of practice for verifying the transport algorithm in non-standard beam 
geometries such as oblique incidence, inhomogeneities, and small field 
measurements are at the discretion of the clinical physicist. In the literature, 
experimental benchmarks were performed with a variety of slab heterogeneous 
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phantoms and agreement between Monte Carlo calculations and measurements are 
observed to be within 2 to 5% (Cygler et al., 2004; Edimo et al., 2013; Hu et al., 
2008). However, measurements of dose distribution near inhomogeneous 
boundaries are lacking due to physical limitations of the measurement device. This 
study hopes to overcome the ionisation chamber and diode limitations by 
introducing a measurement method that utilises radiochromic film in water to 
provide full scatter conditions. 
 
2.8 Experimental Design 
Using radiochromic film in water had been explored previously by various 
investigators (Arjomandy et al., 2012; Xu et al., 2009) and is proven to be an accurate 
dosimeter. Arjomandy et al. investigated EBT2 film as a depth dose measurement 
over a wide range of energies and modalities (Arjomandy et al., 2012). Relative 
depth doses were extracted and excellent agreement of less than 2% was seen with 
those measured with ionisation chambers. Zhigang Xu et al. evaluated the eclipse 
electron Monte Carlo dose calculation for small fields and good agreement of within 
4% was observed. Both of these methods use radiochromic film submerged in water 
with the aim to provide a high spatial resolution measurement and no distortion in 
the high gradient regions. Film analysis for both the studies are similar; using 
calibration methods recommended by David Lewis (Lewis, 2012) and the dose 
reported was in relative mode. 
This study focuses on a similar approach of using radiochromic films in water 
but to ensure a reproducible setup, a film holder was designed and manufactured. 
The film calibration and analysis was done with the aim of measuring in absolute 
dose mode. A set of beams were setup to investigate standard uniform fields, the 
effects of oblique incidence, small field sizes and inhomogeneity. The setup includes 
measurements which are more complicated than measuring in the centre of a wide 
field at a depth. An opportunity to explore the dose distribution near the 
inhomogeneity boundaries will be possible with this measurement method. 
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METHODS 
Accurate dose calculation is one of the important aspects between the dose 
prescription and the dose delivery process. Dose calculation is performed by a 
treatment planning system (TPS) which needs to be clinically implemented. 
Implementation of a TPS involves commissioning and validating the beam model 
under conditions similar to those found in clinic. The commissioning process is the 
most crucial part as the accuracy of the delivered dose to the patient is dependent 
on the accuracy of the beam data used. A set of beam data is required by ELEKTA to 
tune the XiO eMC beam model to match the users beam. The beam data collection is 
listed in Appendix A. As recommended by AAPM TG-106 (Das et al., 2008a), 
ionisation chambers, diodes and diamond detectors are well suited for 
commissioning beam data in a scanning water phantom. The experimental validation 
process is another crucial component as it deals with how accurately the algorithm 
performs under different test conditions within a phantom. The types of 
recommended radiation detectors for validation experiments are described in AAPM 
TG-105 (Chetty et al., 2007). However, with the recommended list of detectors, it is 
important to note the variations and associated uncertainties.  Ionisation chambers 
are generally suitable for standard field validation but when used in non-standard 
fields, non-uniform dose regions may introduce a high degree of uncertainty. This 
project aims to verify both standard and non-standard fields by experimentation of a 
novel method for validating dose distributions. Both the commissioning process and 
experimental validation method are described in this chapter. 
 
3.1 Irradiation Units 
The linear accelerator used in this research was a Varian Clinac 21iX (Varian Medical 
Systems, Inc., Palo Alto, CA) which provides 6 MV and 18 MV photons and nominal 
electron energies of 6, 9, 12, 15 and 18 MeV. Three (6, 12 and 18 MeV) out of the 
five electron energies were used in this research. The electron outputs, symmetry 
and mechanical aspects are checked monthly according to tolerances stated in the 
AAPM TG-142 report (Klein et al., 2009). The beams are calibrated once a year by an 
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ionisation chamber and electrometer that have been calibrated at the Australia 
Radiation Protection and Nuclear Safety Agency (ARPANSA). In addition to the 
calibration, a yearly independent dosimetry audit, managed by the Australian Clinical 
Dosimetry Service (ACDS), is performed on the linear accelerators.  
 
3.2 XiO eMC commissioning 
A standard set of water measurements were acquired during commissioning with a 
Varian 21iX linear accelerator (Varian Medical Systems, Inc., Palo Alto, CA). As part of 
the commissioning process, the XiO eMC calculated doses were compared to 
measured doses for these standard beams. 
The commissioning process of a treatment planning system involves acquiring 
scanned and non-scanned beam data. The acquisition of the scanned beam data is 
the gathering of percentage depth dose curves and lateral profiles. The scanned 
beam data was measured using a Wellhöfer CC13 compact chamber and PPC-05 
plane-parallel ionisation chamber in a BluePhantom2 scanning water phantom (IBA 
Dosimetry GmbH, Schwarzenbruck, Germany). The depth of the ionisation chamber 
position was extremely critical in these measurements to obtain accurate data. A 
radius shift of 0.5 Rcyl for cylindrical ionisation chamber reference point of 
measurement is necessary, where Rcyl is the radius of the air cavity. The positioning 
of the chamber is used to avoid the need for fluence gradient correction (IAEA, 
2000). For the parallel plate ionisation chamber, the reference point of 
measurement is taken to be on the inner surface of the entrance window. Scanning 
method recommendations were adopted from AAPM TG-106 protocol (Das et al., 
2008a). The non-scanned beam data required for XiO eMC are the output factors 
taken at a reference depth for each electron energy and applicator. The list of 
required beam data for XiO eMC beam model is specified in the user manual and is 
documented in appendix A. 
 
3.2.1 Percentage depth dose 
Percentage depth dose were taken with a fixed SSD of 100cm. The percentage depth 
ionisation curves were scanned for all energies using a PPC-05 plane-parallel 
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ionisation chamber, for all electron applicators. In addition to the standard fields, the 
percentage depth dose for a 5 x 5 cm2 square cut-out centred in a 15 x 15 cm2 
applicator and an open 40 x 40 cm2 field with no applicator were collected as part of 
the requirements. The scan was performed upwards to the surface of the water 
along the central axis to avoid the water ripple effects. Water ripple could cause the 
depth dose curve to have jagged edges and is more noticeable in the lower energies. 
The scanning beam data was repeated for every applicator at extended SSD of 
110cm and 115cm. The percent depth ionisation curve was converted to depth dose 
curves using correction factors and restricted stopping power ratios from the TRS 
398 protocol (IAEA, 2000). The PDD beam data was processed with the least squares 
smoothing routine. 
 
3.2.2 Lateral profiles 
Lateral profiles at the depth of 0.5 cm, depth of maximum dose (Dmax), depth at 90% 
(R90), 80% (R80), 50% (R50), 20% (R20) of Dmax and the practical range (RP) + 2 cm were 
scanned for all energies and electron applicators. The lateral profiles of a 5 x 5 cm2 
square cut-out centred in a 15 x 15 cm2 applicator and an open 40 x 40 cm2 field with 
no applicator were acquired. The 40 x 40 cm2 field scans are required for modelling 
the particle fluence incident upon the applicators (Vandervoort et al., 2014). The 
choice of chamber is critical for profile measurements due the effect of volume 
averaging when measuring in the high gradient penumbra region. It is recommended 
by AAPM TG-106 that a small volume detector is preferred for profiles. Both in-plane 
and cross-plane profiles were acquired using a CC13 compact ionisation chamber. 
During linear accelerator commissioning, in-plane and cross-plane scans were 
acquired and both the symmetries were found to be less than 1%. There is a 
difference between the in-plane and cross-plane profiles in the shoulder. However, 
the difference was insignificant and therefore only cross-plane profiles were used for 
beam modelling. The lateral profiles were smoothed using a median smoothing 
function that preserves the gradient, then centred and made symmetric. The mean 
values of both sides were used to calculate the symmetric curve. The profiles were 
made symmetric because the beam model does not reproduce beam asymmetry. 
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The beam symmetry for the linear accelerators used in this work was maintained at 
less than 2%.  
 
3.2.3 Output Factors 
For each electron energy, a single reference depth of Dmax was chosen to measure 
the output factor. The output factor is defined as the ratio of dose at Dmax for a given 
applicator to the dose at Dmax for the reference applicator of 10 x 10 cm
2. The factors 
can be measured either in a water phantom or in solid phantom with a PPC-05 
plane-parallel ionisation chamber. During commissioning, the factors were measured 
in the BluePhantom2 water phantom for consistency. The output factors were 
measured for every field and SSD listed for PDD and profiles measurement.  
 
3.2.4 Model Validation 
The beam models were created by Elekta using the acquired beam data during 
commissioning. It is necessary to perform validation measurements of the Monte 
Carlo algorithm to evaluate how accurately the algorithm performs under different 
test conditions. The evaluation of beam model accuracy was performed by 
comparing the calculated and measured depth dose and profiles in a homogeneous 
water phantom for a range of field sizes. The cut-out factors were measured and 
compared to XiO eMC for each energy and range of applicators. The cut-out shapes 
validated include circular, ovals, squares and rectangles with field sizes ranging from 
3 cm to 16 cm in diameter or length.  
Recommendations for TPS validation tests are generally in homogeneous and 
heterogeneous phantoms; however issues related to electronic disequilibrium are 
excluded. Experimental validations should also be performed in more clinically 
relevant situations (Chetty et al., 2007). This thesis explores the possibility of 
validating the electron Monte Carlo dose distributions in conditions other than the 
standard measurements.  
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3.3 Film holder design 
This section covers the development of the water phantom, the design and 
construction of the various components made for this project. The original idea for 
using radiochromic films in water to validate 2D dose distributions was introduced by 
Xu, Z. et al. (Xu et al., 2009). Xu, Z. et al. evaluated the electron Monte Carlo dose 
calculation algorithm in the Eclipse treatment planning system. The old rule of 
thumb (beam energy in MeV / 2.5 in centimetres) to approximate the limiting cut-
out size of an electron field was investigated for small circular fields. In the study, Xu, 
Z. et al. compared eMC calculations and relative measurements of depth doses and 
isodose distributions using EBT film in water. However, in this work, a more 
reproducible setup was designed and constructed to hold the films vertically in 
water. 
All measurements were done in water to avoid air gaps that may be present 
when using solid water phantoms. A small portable water phantom, as shown in 
figure 3.1, was designed and constructed to hold film in a highly reproducible setup. 
It contains a U-Shaped holder made from PMMA to support the film in a vertical 
orientation. The film holder is suspended in water by the support of two rail holders. 
The film sits in a slit of less than 1 mm in the middle of the U-shaped holder. The U-
shaped holder measures 29.5 x 29 cm and fits a full sized EBT3 film. The 
measurement setup is shown in figure 3.2. This phantom allows the film to measure 
the 2D dose distribution in a transverse plane. To align the film edge to the water 
surface, first the SSD to the film is set using a calibrated front pointer as shown in 
figure 3.3. Then the tank is offset longitudinally to set the water level to the end of 
the calibrated front pointer by using the treatment couch. This is to ensure that both 
the water level and the edge of the EBT3 film are at the desired SSD. The 
reproducibility of the film setup is ±0.5 mm or less. 
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Figure 3.1 U-Shaped holder and water phantom to support radiochromic film. 
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Figure 3.2 U-Shaped holder measurement setup with a Varian 21iX linear 
accelerator. 
 
  
Figure 3.3 Aligning the film edge to the water surface at source-to-surface distance 
of 100 cm. 
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3.4 Film Calibration 
To establish the dose response calibration curve for electron beams, films from 
batch #A01231204 were cut to 4x4 cm size. The pieces of film were marked on the 
top right hand corner to keep track of the orientation. It is important to note the film 
orientation as the scanner response varies with different orientation (Reinhardt et 
al., 2012). Electron beams from a Varian 21iX linear accelerator were used to 
irradiate the films. Doses ranging from 10 to 600 cGy were delivered with a 12 MeV, 
10 x 10 cm2 field and at a depth of dose maximum (2.9cm) in a CIRS Plastic Water® 
phantom (Computerized Imaging Reference Systems, Inc., Norfolk, VA). The water 
equivalence of Plastic Water had previously been established by comparing doses 
measured in Plastic Water with doses in real water, according to TRS398 (IAEA, 
2000). For the 12 MeV electron beam used for calibration, doses agreed to within 
0.4%. Using a 12 MeV electron beam is suitable for defining the calibration curve due 
to the region of low dose gradient at depth of maximum dose extending over a 
greater depth than the lower energies. 12 MeV is also in the middle of the energy 
range that is investigated for this work. Repeat calibration measurements from the 
same batch of film were performed to determine the uncertainty in the film 
measurement at doses ranging from 10 to 600 cGy. 
Calibration films were scanned on the same side consistently with the help of 
the same orientation marker on the top right hand corner of the films. This is to 
eliminate any orientation dependence whilst scanning. As shown in figure 3.4, the 
films were lined up in two rows, five films in each row, along the centre of the scan 
plane. After scanning the calibration films, a region of interest in the centre of the 
film is selected and the absolute dose values were assigned respectively based on 
the measured linear accelerator output at the time of film calibration (see section 
3.3.1). An example of the calibration curve generated by the SNC software is shown 
in figure 3.5. The red curve represents the linear plot between the calibration points 
and the green curve represents the exponential fitted curve. SNC Patient software 
uses the exponential fitted calibration curve to convert the scanner response to 
dose. 
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Figure 3.4 Calibration films on an EPSON 10000XL flatbed scanner. 
 
 
Figure 3.5 GafChromic® EBT3 calibration curves generated by SNC Patient software. 
The red curve represents the linear interpolation between calibration points and the 
green curve represents the exponential fitted curve. 
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3.4.1 Linear Accelerator Output 
Linear accelerator output can fluctuate daily. To correct for the linear accelerator 
variation of dose delivered during calibration, the absolute dose-to-water was 
determined in accordance to TRS398 protocol (IAEA, 2000). The linear accelerator 
was calibrated to deliver 1 cGy/MU to the depth of dose maximum for all electron 
energies. The output for 12 MeV, 10 x 10 cm2 field with standard insert was 
determined using a Wellhöfer PPC-05 plane-parallel ionisation chamber connected 
to a DOSE1 electrometer (IBA Dosimetry GmbH, Schwarzenbruck, Germany). 
Measurements were done at a reference depth of 2.9cm. The chamber’s calibration 
factor is traceable to Australian Radiation Protection and Nuclear Safety Agency 
(ARPANSA) which is the National Standards Laboratory. The ionisation chamber was 
placed in Solid Water with a PMMA build-up cap. Ambient temperature (T) and 
pressure (P) corrections were applied to the measured charge (nC). A temperature 
and pressure correction factor ('() is calculated using equation 3.1.  
 
 '(  273.2 + *	(°')293.2	(°') 101.3,-.-	(,-.)  (3.1) 
 
To determine the linear accelerator output, the absolute dose delivered per 
monitor unit (cGy/MU) at depth of maximum dose is calculated using equation 3.2. 
 
 /01201(#3.4) =  × '( × *'6789:;(<;:=) × -'6 ×
100
-##>?@A
 
(3.2) 
Where,  
/01201(#3.4) is the absolute dose delivered per monitor unit at the depth of 
maximum dose. 
M is the electrometer reading (nC). 
'( is the temperature and pressure correction factor. 
*'6789:;(<;:=) is defined as the total correction factor at <;:= which consists of the 
dose to water cross calibration factor (B7CD;EFF) at the measured energy, 
ionisation chamber response (,GCD;EFF) and polarity (H) and recombination (HF) 
ionisation chamber corrections. 
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-'6 is the phantom correction factor for using solid water instead of water. 
-##>?@A  is the percentage depth dose at reference depth (<;:=). 
This is an important step to reduce the impact of linac variations in output on 
film uncertainties. Since a fixed amount of MUs were delivered, the absolute dose to 
film can be adjusted based on the linear accelerator’s output during film calibration. 
 
3.5 Film Handling and Scanning 
Radiochromic films will begin to develop as soon as they are irradiated and will 
continue to develop with time. Irradiated films were given a minimum of 48 hours to 
stabilise before scanning.  
To minimise the effect of post exposure changes in the film, calibration and 
measurement films were exposed within a 2 hour interval. Irradiated films were 
scanned with an EPSON Expression 10000XL (EPSON Deutschland GmbH, Meerbusch, 
Germany) flatbed scanner using methods described by Lewis (Lewis, 2012). Scans 
were performed in transmission mode with a resolution of 75 dpi and no colour 
correction was applied. 48-bit RGB scanned images were saved in Sun Nuclear 
Patient (Sun Nuclear Corporation, Melbourne, FL) software film format. Scanning of 
the film was done via an Epson Scan v3.49E (Seiko Epson Corporation, Suwa, Nagano, 
Japan) software. Films were aligned on the scanner using reference points marked 
on film and scanner surrounds. The SNC Patient Film QA module was used to scan 
and import the films. The EPSON software is launched automatically from the Film 
QA module during the scanning process. The scanned film image is saved as a SNC 
Patient film dose file format (.flm).  
Seven preview scans were taken to allow the scanner to stabilise (Ferreira et 
al., 2009) and films were placed consistently in the middle of the scan window in 
landscape orientation to minimize the effects of non-uniformity of scanner response 
(Sorriaux et al., 2012). The lateral response of a flatbed scanner was previously 
investigated and showed differences of up to 11% when films are scanned at the 
edges (Menegotti et al., 2008). To assess the effects of possible film heterogeneities 
and any non-uniformity of scanner response, unexposed films were scanned in the 
standard orientation and also rotated by 180°. The same scanner and analysis 
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settings as in the rest of this work were used. The red colour channel was selected to 
import the film as it has been shown to have the highest sensitivity to dose 
(Casanova Borca et al., 2013; Ferreira et al., 2009; Cygler et al., 1987). 
 
3.6 Film Analysis 
Comparisons of calculated XiO eMC dose planes with radiochromic film 
measurements were done using SNC Patient™ software version 6.2.3 (Sun Nuclear 
Corporation, Melbourne, FL) and depth dose profile comparisons were done in 
Microsoft Excel (Microsoft, Redmond, WA). To fine tune the alignment of the film 
and calculated 2D dose distributions, the ‘Calc Shift’ option in SNC Patient software 
was used. The highest resolution of the scanned films is 1 mm and the calculated 
dose was shifted along the X and Y axis by ± 1 mm to achieve the highest passing 
rate. 
All 2D comparisons of EBT3 and XiO eMC were done by comparing absolute 
dose per monitor unit (MU). The SNC Patient software gamma dose analysis was 
used to compare the overall 2D dose distributions and the distance-to-agreement 
(DTA) tool was used to compare doses in regions with steep gradients (Venselaar et 
al., 2001). Gamma analysis is a measure between measurement and calculation 
points in both dose and physical distance in space (Low et al., 1998). Gamma analysis 
combines dose difference (DD) and DTA criteria to calculate a dimensionless metric 
for each point in the evaluated distribution (Hussein et al., 2013). A gamma of less 
than 1 indicates that the points lie within either the DD or DTA passing criteria. For a 
given DD/DTA criteria, the fraction of points that achieve a gamma < 1 is calculated 
and reported as a percentage of points that passed. A threshold is set where the 
minimum dose percent value must be met for the point to be included in the 
analysis. The purpose of this threshold is to exclude low dose regions or out of field 
doses during comparison and a typical value of 10% was used for all gamma 
comparisons.  For standard fields, the gamma evaluation criteria were set to 2% and 
2 mm. For the non-standard fields, the gamma evaluation criteria were set to 3% and 
3 mm. These criteria align with TRS430 recommendations for simple and complex 
geometries respectively (IAEA, 2004). 
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3.7 Film method validation 
3.7.1 Ionisation chamber and EBT3 film comparison 
The film measurement method was validated by comparing EBT3 film measurements 
and ionisation chamber measurements taken in a Scanditronics Wellhöfer 
BluePhantom2 scanning water phantom using the OmniProTM Accept 7.1a scanning 
software (IBA Dosimetry GmbH, Schwarzenbruck, Germany).  
A lateral profile from the EBT3 film measurement was used to compare CC13 
ionisation chamber. Measurements were performed with a 12 MeV electron beam 
defined by a 10 x 10 cm2 square field at 100 cm SSD. 
The accuracy of the film calibration method was verified by comparing EBT3 
depth dose profiles from films irradiated parallel to the beam axis in the portable 
water phantom, to measurements with a PPC05 parallel plate ionisation chamber. 
The acquired depth ionisation data were converted to depth doses with the 
OmniProTM software using the IAEA TRS398 protocol (Williams and Thwaites, 2000). 
Ionisation chamber and EBT3 depth doses were compared in terms of absolute dose 
(cGy/MU) for 6, 12 and 18 MeV for a 10x10 cm2 field at 100 and 105 cm SSD. 
 
3.7.2 Effect of film rotation 
In addition to the cross-plane measurements, an in-plane measurement was 
performed by rotating the water phantom and film by 90° and irradiated with a 45° 
gantry beam angle. Figure 3.6 a) shows the film being irradiated by a 45° angle beam 
with no tank rotation. Figure 3.6 b) shows the water tank setup rotated by 90° 
irradiated with the same 45° angle beam. The central axis depth dose curves for both 
orientations were compared. This validation method verifies that the radiochromic 
film reveals no difference when measuring in both cross-plane and in-plane 
orientations. 
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Figure 3.6 a) 45° gantry angle beam irradiating EBT3 film in the cross-plane 
orientation. b) EBT3 film positioned in the in-plane orientation irradiated by the 
same 45° gantry angle beam. 
 
3.7.3 Film scanning validation 
The variation of optical density within the scan window was investigated for the 
EPSON 10000XL scanner used in this project. A piece of unexposed film was scanned 
in the middle and at the edges of the scanning window. The difference in optical 
density was recorded. 
 
3.8 Uncertainty of Methods 
This section identifies the reproducibility of the film measurement and processing 
method. The measurement and scanning uncertainty was investigated and is 
described below. All uncertainty results were analysed and extracted from SNC 
Patient™ software. 
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3.8.1  Scanner uncertainty 
Scanner reproducibility was investigated. The scanning reproducibility was analysed 
with a single film that was irradiated with 400 MUs using a 6 MeV beam, 3 cm 
diameter applicator insert in a 6 x 6 cm2  electron applicator. Five consecutive scans 
were performed for the single film at the centre of the scanning window and for 
each individual scan the dose and depths at Dmax, R90, R50 and RW50  were recorded. 
 
3.8.2 Measurement uncertainty 
The reproducibility of the method was investigated by comparing five films 
irradiated in identical conditions in the same measurement session. The 
measurement was irradiated with 400 MUs using a 6 MeV beam, 3 cm diameter 
applicator insert in a 6 x 6 cm2  electron applicator. Each film was scanned once in the 
centre of the scanning window. The dose and depths at Dmax, R90, R50 and RW50 were 
recorded for five films. The measurement uncertainty includes the reproducibility of 
irradiations and the reproducibility of the scanner. 
 
3.8.3 2D Gamma Analysis uncertainty 
The reproducibility of SNC Patient™ software 2D analysis results was investigated. 
The film software analysis process was performed using the five films from the 
measurement uncertainty investigation (section 3.8.2). XiO eMC 2-D dose 
distribution for a 6 MeV beam, 3 cm diameter insert in a 6 x 6 cm2 electron applicator 
was used to perform the 2D analysis. The SNC Patient™ software reported gamma 
passing percentages were recorded. 
 
3.9 CT number and Relative Electron Density 
To correct for tissue heterogeneities for CT based treatment planning, the 
relationship between the CT number and electron density must be established (Saw 
et al., 2005). Electron beams used are in the mega-electron volt (MeV) range and 
interact with matter principally by ionisation and excitation. XiO uses Monte Carlo 
algorithm to calculate dose deposited in tissue. As described in section 2.4.9, Monte 
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Carlo simulations can take tissue inhomogeneity into account by mapping CT 
numbers to an electron density table. Hence, a CT number (HU) to relative electron 
density conversion curve is needed for medium characterisation. The conversion is 
generally established by scanning a tissue characterisation phantom such as the CIRS 
Model 062 (CIRS Tissue Simulation Technology, Norfolk, VA). As shown in the figure 
3.7, the CIRS phantom with multiple inserts of different simulated tissue composition 
and the corresponding scanned CT image. To determine the mean CT values and 
their standard deviation, regions of interest were drawn within each insert. 
 
Figure 3.7 Tissue characterisation phantom CIRS Model 062 (left) and axial CT image 
of the phantom (right) taken at 140 kVp tube voltage. 
 
To determine the RED for heterogeneity calculations, the materials (cork, 
Perspex and Teflon) used to create the configurations in figure 3.8 were scanned in a 
water phantom with a Brilliance Big Bore CT scanner. The scanning parameters were 
set to 4 x 0.75 collimation, field of view (FOV) of 180 mm and 3 mm increment. The 
average CT numbers were extracted from each material and were fitted to the CT to 
RED curve. 
 
3.10 Film measurement and comparison 
To extend the standard set of commissioning measurements to include clinically 
relevant conditions, measurements of standard fields, oblique incidence, small 
circular fields and inhomogeneity were designed to focus on specific geometries that 
are difficult or impossible to assess using ionisation chambers. Measurements were 
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performed with electron energies of 6, 12 and 18 MeV from a Varian 21iX linear 
accelerator (SN #4907). 
In regions of shallow dose gradient, the dose comparison is straightforward. 
However, in steep dose gradient regions, the dose difference is sensitive to small 
spatial offsets (Low et al., 1998). The DTA component of the gamma analysis was 
used to compare steep dose gradient regions like penumbras and depth dose curves.   
The concept of distance to agreement (DTA) was developed by Van Dyk (Van Dyk et 
al., 1993) to compare high dose gradient regions. DTA is a measure of the nearest 
point in the measured distribution that is within a dose tolerance criterion. 
Point dose comparison was done at depth of maximum dose (Dmax). The XiO 
point doses used in the comparison includes the uncertainty of 1% as specified by 
the MRSU parameter. DTA was used to analyse doses at the depths of 90% (R90) and 
50% (R50) of the maximum dose. The calculated and measured radiological widths 
(RW50) were also compared at Dmax. 
 
3.10.1 Standard field measurements 
For film holder validation purposes, standard fields were measured using a 10 x 10 
cm2 electron applicator at 100 cm SSD and a 6 x 6 cm2 electron applicator at 105 cm 
SSD. 
 
3.10.2 Obliquity measurements 
Obliquity measurements were performed using gantry angles of 0°, 25° and 45°. The 
standard applicator insert with a field size of 6 x 6 cm2 at SSD of 100 cm was used. To 
provide clearance for the electron applicator at gantry angle of 45°, the water 
phantom had to be offset laterally as shown in figure 3.6(a).  
 
3.10.3 Small circular fields 
For small fields, circular Cerrobend inserts of 2, 3, and 6 cm diameter (figure 3.8) 
were made in-house and the actual aperture size was verified with XiO printouts at 
100 cm SSD. Measurements using the 2 and 3 cm diameter applicator inserts were 
63 
 
performed with a 6 MeV beam. Measurements using the 3 and 6 cm diameter 
applicator inserts were performed with 12 and 18 MeV beams. 
 
3.10.4 Inhomogeneity measurements 
Inhomogeneity measurements were performed with 3 materials (figure 3.8); cork 
mimicking lung, Perspex mimicking rib bone, and Teflon mimicking skull bone. The 
physical densities and relative electron densities (determined experimentally in 
section 3.9) of the materials can be found in Table 3.1. 
These materials were cut into sizes as shown in table 3.1 and are positioned by 
sticking them on both sides of the film using adhesive tape that left no marks on the 
film (Figure 3.8). The inhomogeneity phantoms were irradiated with a 10 x 10 cm2 
field for rib and lung configuration and 6 x 6 cm2 field for skull bone configuration at 
100cm SSD.  
Since the film is calibrated for dose-to-water but XiO eMC calculates dose-to-
medium, a conversion from film dose-to-water to “film derived” dose-to-medium 
was performed using mass collision stopping power ratios for the rib bone and skull 
phantom to enable better interpretation of the result. As described in AAPM TG21 
(Paul et al., 1985), dose-to-water is related to dose-to-medium by 
 #789:;  #I:BJKI̅ M⁄ I:BJKI789:;  3.3 
 
where ̅ M⁄ I:BJKI789:;  is the ratio of the average unrestricted mass stopping power of 
water to the medium in question.  
 A mean electron energy of 3 MeV was assumed in all regions. The stopping 
power varies according to the electron energy spectrum and is a function of depth. 
This conversion has been described by Aubry et al. (Aubry et al., 2011). Without a full 
Monte Carlo simulation, an approximation of the mean energy was made using the 
method described in AAPM TG21 (Paul et al., 1985). This approximation has been 
shown to overestimate the beam energy at depth (Ding and Rogers, 1996). However, 
there is negligible change in collision mass stopping power ratios of medium to water 
(calculated using Table A.8, (Khan, 2003)) over the energy range of 1-4 MeV. This 
64 
 
ensures that this approximation is not highly sensitive to choice of energy at depth. 
Stopping power ratios were calculated for skull bone and for rib bone using the 
experimental surrogates for these materials i.e. Teflon and Perspex respectively. The 
surrogates were chosen as they have relative electron densities that closely match 
the biological materials. No stopping power ratio corrections are applied to the 
measurements in cork (lung) since the stopping power are equivalent to those in 
water (Aubry et al., 2011). 
 
Table 3.1 Physical dimensions and density of the materials used in the 
inhomogeneity measurements. 
Materials 
Dimensions: Height x 
Width x Length (cm) 
Physical Density 
(g/cm
3
) 
CT number 
(HU) 
Relative Electron 
Density 
Teflon 1 x 8 x 3 2.2 913.75 1.61 
Perspex 1 x 1 x 3 1.18 109.66 1.13 
Cork 5 x 8 x 3 0.24 -656.94 0.34 
 
Figure 3.8 Circular field applicator insert of 2 and 3 cm diameter (left)  and cork, 
Perspex and Teflon materials used for inhomogeneity measurements (right). 
 
Figure 3.9 Ribs and lung (left) and skull (right) phantom fixed on both sides of the 
EBT3 film for inhomogeneity measurements. 
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3.11 Treatment planning calculations 
To simulate the measurement setup in XiO, a water equivalent phantom of 30 x 30 x 
30 cm was created for the standard field, obliquity and small circular field 
measurements. For the inhomogeneity measurements, the same configuration of 
cork, Perspex and Teflon materials were created with the dimensions as shown in 
Figure 3.10. The relative electron density (RED) assigned to each of these materials 
are specified in table 3.1. 
The XiO eMC algorithm V4.80.03 was used for all calculations. The XiO eMC 
dose calculation parameters, as described in section 2.4, were established at the 
time of commissioning and are listed in table 3.2. Whilst the MRSU of 2% is used 
clinically, for the purpose of this work, a goal MRSU of 1% was used to reduce the 
statistical uncertainty. Dose to water was calculated for all field geometries to mimic 
the dose delivered to the film which is calibrated to provide dose to water. Depth 
doses for all electron energies (6, 9, 12, 15 and 18 MeV) were calculated for the 
reference field size of 10 x 10 cm2 at 100 cm SSD. The calculated depth doses for the 
reference field were compared against ionisation chamber depth dose 
measurements. 
 
 
Figure 3.10 Phantom configurations created in XiO for (a) Rib and lung phantom 
consisting of Perspex and cork and (b) skull phantom made from Teflon. 
 
 
a) Perspex 
Cork 
Water 
1 cm 
5 cm 
8 cm 
b) 
Teflon 
Water 
8 cm 
1 cm 
1 cm 1 cm 
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Table 3.2 XiO eMC and dose calculation parameters used clinically. 
 
 
 
 
 
 
 
 
 
Calculations were performed for three out of the five electron energies 
available at our institution (6, 12 and 18 MeV). For standard field calculations, beams 
were created for a 10 x 10 cm2 field at 100 cm SSD. For oblique beams, the dose for a 
6 x 6 cm2 field at 105 cm SSD for gantry angles of 0°, 25° and 45° was calculated. 
Calculations of small circular field sizes were performed for 2 and 3 cm diameter 
inserts for 6 MeV and 3 and 6 cm diameter inserts for 12 and 18 MeV using a 6 × 6 
cm2 electron applicator at 100 cm SSD. Inhomogeneity calculations were done for 
two configurations as shown in figure 3.10. Figure 3.10 (a) is a water phantom 
containing heterogeneities mimicking ribs overlying lung tissue. Figure 3.10 (b) 
contains a heterogeneity mimicking the bone underlying the scalp. The 
inhomogeneity materials were placed at a depth 1 cm from the surface of the 
phantom. For the inhomogeneity calculations, the grid size was reduced to 0.1 cm to 
provide better spatial resolution and interpretation at the interface. Dose-to-
medium was also calculated within the other materials for comparison with XiO 
converted dose-to-water and film derived dose-to-medium.  
The calculated 2D distributions were exported to file (.txt) from XiO and 
directly imported to SNC Patient software using the CMS XiO file format option.  
  
Parameter Values 
Maximum number of histories 1.00E+12 
Goal MRSU 2% 
MRSU threshold 50% 
Dose update interval 500000 
Random number generator seed 1802 
Calculation grid size 0.2 cm 
Calculated absorbed dose Water/ Medium 
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RESULTS 
4.1 XiO eMC commissioning and validation 
The XiO eMC beam models were generated from the measured beam data by 
ELEKTA CMS software. The PDD curves were used to determine the energy spectrum 
of each beam. The measured output factors were used to match applicator output 
factors during beam modelling. The computed dose distributions were matched to 
measured data and reports were generated for each energy and applicator at 100 
cm SSD and at extended SSD of 110 cm. An example of the report is shown in 
Appendix B. ELEKTA claims that the generated beam models achieve 2% / 2 mm 
accuracy throughout most of the dose distributions. This section aims to validate the 
accuracy of the beam model by comparing the measured and XiO calculated depth 
dose curves and profiles. The depth dose curves are normalised to 100% at the 
maximum and profiles at Dmax are normalised to their central axis value. Only 6, 12 
and 18 MeV depth dose curves and profiles of a 10 x 10 cm2 field defined by an 
electron applicator are included in this section. For validation purposes, all XiO doses 
were calculated with dose-to-water in a 30 cm3 homogeneous phantom created in 
XiO. The calculation voxel size used in this study was 0.2 cm3. The statistical 
uncertainty was set to 1% and the number of histories of 1.00 E+12 was used in all 
the calculations. 
 
4.1.1 Percentage depth dose 
Figure 4.1 shows the measured and XiO calculated percent depth dose curves for a 
field defined by a 10 x 10 cm2 applicator for electron beam energies of 6, 12 and 18 
MeV. Beyond the depth of maximum dose, excellent agreement of less than 0.5 mm 
between measured and calculated is seen across all electron energies. Discrepancies 
between measurements and calculations are observed near the surface and this 
could be due to the lack of resolution from the PPC05 ionisation chamber.  
 
68 
 
 
 
Figure 4.1 Comparison of measured and eMC calculated central axis depth dose 
curves for electron beam energies of 6, 12, and 18 MeV defined by a 10 x 10 cm
2 
electron applicator.  
 
4.1.2 Lateral Profiles 
The lateral dose profiles were acquired at various depths specified in the beam data 
collection list (Appendix A) and were compared to the water tank measurements. In-
plane profiles were excluded as Blue Phantom 2 scans show that the in-plane and 
cross-plane symmetry to be similar, where the difference between the two is very 
minimal at the shoulder of the profiles. Figures 4.2 (a) – (c) shows the comparison 
between measured and XiO calculated cross-plane dose profiles for 6, 12 and 18 
MeV defined by a 10 x 10 cm2 field. The profiles were measured and calculated at 
SSD of 100 cm. The measured and XiO calculated dose profiles are in good 
agreement of less than 1 mm at the penumbra region. 
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Figure 4.2 Comparison of measured and calculated XiO cross-plane dose profiles at 
depths of Dmax, R90, and R50 for (a) 6 MeV, (b) 12 MeV and (c) 18 MeV with a 10 x 10 
cm
2 
applicator defined field. 
 
4.1.3 Output factors 
The output was measured and the accuracy was validated at the depth of dose 
maximum for all electron energies with a range of circular, oval and square cut-out 
shapes. The output factors were single measurements; however, they were 
compared to reference data measured on two matched linear accelerators within 
the organisation. The agreement between measured and reference data are within -
0.2 ± 1.0% (2SD). Good agreement is seen overall between measured and calculated 
output factors. There is a slight increase in output factor for the 6 MeV beam from 6 
cm to 7 cm field size where the applicator size changes from 6 x 6 cm to 10 x 10 cm. 
This is due to the greater sensitivity to changing applicator scatter at this energy. The 
same jaw sizes are used for the 6 x 6 cm and 10 x 10 cm applicator. Only circular field 
output factors are shown in figures 4.3 (a) – (c) for 6, 12 and 18 MeV. The results 
obtained for the other energies and cut-out shapes are similar in comparison. The 
calculation voxel size of 2 mm was used in all cases. The statistical uncertainty in the 
calculation was less than 1%. The agreement between calculated and measured 
output factors are all within 2% except for the smaller field sizes for energies above 
12 MeV.  
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Figure 4.3 Comparison of measured and calculated output factors for 100 and 110 
cm SSDs for (a) 6, (b) 12 and (c) 18 MeV electron beam.  
 
4.2 Film Calibration 
During film calibration, the linear accelerator output for the 12MeV beam was 
measured and yielded a result of 1.009 cGy/MU. The film was irradiated with a range 
from 10 to 600 MU. Figure 4.4 shows the dose response curve averaged from the 
two repetitions which was scanned using the red channel. Repeat calibrations from 
the same batch of film showed that the uncertainty in film response at doses of 10 
and 600 cGy are ±10% (2σ) and ±2% (2σ) respectively. When the uncertainty in 
scanner response and the uncertainty in the calibration doses, measured according 
to TRS 398, are taken into account the total uncertainty in the film measurement at 
10 and 600 cGy is ±12% (2σ) and ±4% (2σ) respectively. This is similar to results 
reported by Sorriaux et al., the total uncertainty is close to ±3% (2σ) at 200cGy for 
6MeV electrons with EBT3 (Sorriaux et al., 2013). Similarly to Sorriaux et al., only two 
repetitions of electron calibration with the same batch of films were performed 
whereas three repetitions would have improved the estimate of the uncertainty. 
 
0.300
0.400
0.500
0.600
0.700
0.800
0.900
1.000
1.100
0 2 4 6 8 10 12 14 16 18
O
u
tp
u
t 
fa
ct
o
r
Field size (cm)
18 MeV
XiO eMC 100cm SSD
Measured 100cm SSD
XiO eMC 110cm SSD
Measured 110 cm SSD
(c)
73 
 
 
Figure 4.4 Dose response curve of Gafchromic® EBT3 film in the red channel. Dose 
dependent error bars of ±2σ are shown. 
 
4.3 Film method validation 
4.3.1 Ionisation chamber and EBT3 film comparison 
To confirm the validity of the film dose distribution, a lateral profile film 
measurement was compared to water tank measurements using a CC13 ionisation 
chamber. Measurements were performed with a 12 MeV electron beam defined by a 
10 x 10 cm2 square field at 100 cm SSD. The results are presented in figure 4.5. The 
lateral profiles agree to within 0.5mm within the penumbra region. 
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Figure 4.5 Comparison of a lateral profile at Dmax between CC13 ionisation chamber 
and film for a 10 x 10 cm
2 
field with standard insert at 100 cm SSD. 
 
 
 
Figure 4.6 Depth dose profile comparison between PPC05 ionisation chamber and 
film for 6, 9, 12, 15 and 18 MeV in a 10 x 10 cm
2 
field with standard insert at 100 cm 
SSD. 
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A similar comparison was performed for the depth dose profile. The water tank 
measurements were taken using a PPC05 plane parallel ionisation chamber. The film 
was placed vertically using the water tank setup method mentioned in section 3.2. 
Figure 4.6 shows the depth dose comparison between PPC05 ionisation chamber and 
EBT3 film. The agreement between EBT3 and PPC05 absolute depth dose profiles 
were within 2% or 2 mm. Slightly larger difference of up to 3% were seen in the 
region around Dmax and near the surface. Discrepancies of up to 2% of the max dose 
were also observed at the low dose Bremsstrahlung tail. 
There is almost 100% difference of local dose seen in the low dose 
Bremsstrahlung tail of figure 4.6. Sorriaux et al. showed a difference in EBT3 
response between electrons and photons at low dose, with photon response being 
consistent with the findings of this work for the same dose level (Sorriaux et al., 
2013). This is a likely explanation of why EBT3 doses are almost double the PPC05 
doses in the Bremsstrahlung tail when a calibration curve based on electron doses is 
used in this region.  
 
4.3.2 Effect of film rotation 
The effect of film orientation was investigated by irradiating two pieces of film, one 
in the cross-plane and the other in the in-plane orientation with a 12 MeV at 45° 
beam angle defined by a by a 10 x 10 cm2 field. The central axis depth doses were 
extracted from both films and plotted on the same graph, normalising at the 
maximum dose. The relative depth dose comparison in figure 4.7 shows good 
agreement to within 2% or 0.5 mm between the transverse and sagittal orientation. 
This is of the same order as the combined measurement and scanning uncertainty, 
indicating that there is very little orientation dependence and radiochromic film 
attenuation is very similar to water. 
 
76 
 
 
Figure 4.7 Depth dose comparisons between cross-plane and in-plane film 
orientation irradiated with a 12 MeV at 45° beam angle defined by a 10 x 10 cm
2 
field. 
 
4.3.3 Film scanning validation 
The variation of optical density for unexposed film was found to be less than 0.5%. A 
very small variation in scanner response in the direction orthogonal to the scan 
direction was observed. This variation was 0.02% per mm, or a maximum of less than 
2% for the largest fields scanned in this work. Both of these effects are small and are 
accounted for in the overall uncertainty of the measurement and scanning process. 
 
4.4 Uncertainty of Methods analysis 
The reproducibility of the film measurement and processing method was 
investigated. The scanner, measurement and software analysis uncertainty is 
reported in this section. All uncertainty results were calculated to 2 standard 
deviation (2σ). 
 
4.4.1 Scanner uncertainty 
The scanning component of the analysis method was investigated with a single film 
scanned five consecutive times. The mean and uncertainty of the dose at Dmax for 
this film was 356.97 ± 1.11 cGy (2σ) or 356.97 cGy ± 0.31% (2σ). This represents the 
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uncertainty on the dose measurement due to the scanning process. All distance 
measurements from the five scans, namely Dmax, R90, R50 and RW50, were identical to 
within 0.1 cm i.e. the resolution of the SNC Patient software.  
 
4.4.2 Measurement uncertainty 
The reproducibility of the measurement was assessed by comparing five films 
irradiated under identical conditions in the same measurement session. The mean 
and uncertainty of the dose at Dmax was observed to be 356.95 ± 1.86 cGy (2σ) or 
356.95 cGy ± 0.52% (2σ). Results from the repeat calibration showed that the 
uncertainty in film response at low doses of 10cGy to 20cGy is close to ±9.5% (2σ) 
whilst the uncertainty at doses of 200 to 600 cGy is ±2.5% (2σ).  
Measurements of Dmax, R90 and R50 were 1.22 ± 0.09 cm (2σ), 1.66 ± 0.06 cm 
(2σ) and 2.26 ± 0.05 cm (2σ) respectively. The mean and uncertainty of RW50 was 
2.90 ± 0.02 cm (2σ). These results represent the combined measurement and 
scanning uncertainty. 
 
4.4.3 Total uncertainty 
The total uncertainty in the film measurements includes the scanner and 
measurement uncertainties discussed above as well as the uncertainty in the 
calibration doses. These were measured using a parallel plane chamber according to 
TRS398 protocol with an uncertainty of 1.4% (IAEA, 2000). 
Therefore the total uncertainty in the film measurements at doses of 10 to 20 
cGy is ±10% (2σ) whilst the total uncertainty at doses of 200 to 600 cGy is ±3% (2σ). 
 
4.4.4 2D Gamma Analysis uncertainty 
The reproducibility of the reported gamma passing percentage was determined by 
comparing five films irradiated under identical conditions with the same XiO 2D 
computed data. The mean gamma passing percentage was 97.4 ± 1.15% (2σ).This 
result represents the overall uncertainty of the measurement, scanning and analysis. 
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4.5 CT number and Relative Electron Density 
As required by XiO treatment planning system for dose calculations, the mean CT vs. 
RED curve was acquired during commissioning. The relative electron density (RED) is 
defined as the electron density (e/cm3) for a particular medium divided by the 
electron density of water (3.343 E+23 e/cm3). Figure 4.8 shows the CT to RED 
conversion curve generated independently at the time of commissioning for a Philips 
Brilliance Big Bore CT scanner (Philips Medical Systems, Cleveland, OH). The data 
points represent the mean CT number for the corresponding RED. There are two 
noticeable gradients of the linear fit on the conversion curve, one from RED of 0 to 
1.15 and the other from 1.15 to 2.00. The non-linearity of the CT to RED curve is 
observed at the transition from water to muscle and bone densities. This is due to 
the change in atomic number which affects the proportion of beam attenuation by 
Compton versus photoelectric interactions (Khan, 2003). CT numbers bear a linear 
relationship with attenuation coefficients but not linear in the entire range of tissue 
densities and material compositions. 
 
Figure 4.8 CT number to Relative Electron Density curve of materials in the CIRS 
Model 062 phantom for a Philips Brilliance Big Bore CT scanner. Red crosses indicate 
the calculated relative electron density of the materials used for inhomogeneity 
measurements. 
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The average CT numbers were extracted from the CT scans of the cork, Perspex 
and Teflon materials. The first trend line ranging from -1000 HU to 150 HU yield an 
equation of y = 0.001x + 1.00 and the second trend line ranging from 150 HU to 2000 
HU yield an equation of y = 0.0006x + 1.07. The RED of the cork, Perspex and Teflon 
materials are calculated by the respective linear equation. As shown in table 3.1, the 
average CT numbers of -656.94 HU (cork), 109.66 HU (Perspex) and 913.75 HU 
(Teflon) yield a RED of 0.34, 1.13 and 1.61 respectively. The RED numbers were used 
to override the density of the phantom configuration created in the XiO treatment 
planning system. 
 
4.6 Film measurement and comparison 
Three of the five commissioned electron beam energies were investigated in this 
study. The electron Monte Carlo calculated depth doses and lateral profiles (1D) and 
dose distributions (2D) were compared to measurements with EBT3 film.  
The reported percentage differences are calculated by comparing the dose 
difference at a point between measured and calculated which is normalised to the 
maximum dose. The agreement between XiO calculated and film measured depth 
doses were quantitatively assessed by determining the DTA at the depths of R90 and 
R50 on the central axis. The depth at R90 is known as the therapeutic range and it is 
often used to prescribe dose. R50 is the depth used to characterise the electron 
beam energy. DTA is used to compare the depth doses as steep dose gradients may 
result in a large percentage difference that is caused by a small difference in depth. 
The lateral profiles are analysed by comparing the radiological widths (the distance 
between 50% of the maximum dose) between XiO calculated and measured film 
profiles. To illustrate the difference between the dose distributions, a comparison of 
2-D dose distribution and dose difference maps were used. Each dose difference 
map shows the film measured dose minus the XiO calculated dose. In the dose 
difference maps, blue indicates measured film is lower than calculated XiO dose and 
red indicates that film is higher than calculated XiO dose. The scales next to the 2-D 
dose distribution represent the dose levels in cGy and the scales next to the dose 
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difference maps represent the absolute dose difference between film measurement 
and XiO calculated dose distribution. 
“Gamma” as described in chapter 3 allows a method for excluding dose-
differences that are due to small spatial offsets in steep dose gradient regions, when 
those small offsets can be regarded as clinically insignificant. Gamma values of ≤ 1 
constitute a pass. One indicator of overall agreement between two dose 
distributions is the number of pixels passing the gamma criteria.  Figure 4.9 (a) shows 
the XiO dose distribution of 12 MeV, 45° oblique incident with blue regions indicate 
where the failing points lie when compared to film. The comparison criteria are 3% / 
3 mm. In this example 4944 out of a total of 5212 points, passed the gamma criteria, 
yielding a gamma passing ratio of 94.9%. Figure 4.9 (b) shows these points in the 
form of a histogram with points that achieved a gamma value of less than 1 (green) 
and failing points where gamma is more than 1 (red). The comparison in figure 4.9 
allow the differences to be observed, and calculating the gamma passing ratio gives 
a quantitative indicator of the magnitude of the agreement (or disagreement). In the 
AAPM TG-119 report, confidence limits were produced as baseline expectation for 
planar dose distributions. Recommended action levels for planar dose distributions 
expressed in terms of percentage points passing gamma criteria of 3%/3 mm is 90% 
for per-field measurements (Ezzell et al., 2009). 
 
Figure 4.9 (a) XiO dose distribution of 12 MeV, 45° oblique incident with blue 
regions indicate where the failing points lie when compared to film. Comparison 
criteria are 3% / 3 mm. (b) A gamma histogram showing the number of passing 
points (green) and failing points (red). 
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4.6.1 Standard field measurements 
Standard field central axis depth dose curves in figure 4.10 show good overall 
agreement. Surface dose agreed to within 0.5% for all beams for the 10 x 10 cm field 
at 100 cm SSD and agreement is mostly within 2%/2 mm beyond Dmax. However, 
slightly larger dose difference of up to 3% is seen in the region around Dmax for the 18 
MeV, 10 x 10 cm2 field. Figure 4.11 shows the comparison of film and XiO 2-D dose 
distribution and dose difference maps for 6, 12 and 18 MeV, 6 x 6 cm2 and 10 x 10 
cm2 fields at 105 cm and 100 cm SSD respectively. It is observed that all measured 
film profiles were consistently narrower than the profiles from XiO. The left side of 
figure 4.11 shows the comparison between film and XiO 2D isodose distributions. 
The isodose distributions show good agreement to within 2 mm. 
The right side of figure 4.11 shows the planar dose difference map for the 
isodose comparison on the left of the figure. For the 6 MeV beams, the largest 
differences were observed where the dose gradient shows the steepest fall-off. For 
all beams, differences are apparent at the edges of the field. These differences are a 
result of the limitation of the SNC Patient software that only allows shifts of 1 mm 
and above when matching dose distributions. This will be discussed further in 
Chapter 5. Dose prediction in the build-up region for XiO is not as accurate because 
depth doses are closely matched at Dmax and beyond rather than in the build-up 
region during beam modelling. The gamma passing rates are above 90% for all fields 
except the 18 MeV, 10 x 10 cm2 field which obtained a gamma passing rate of 85.6%. 
 
82 
 
 
Figure 4.10 Comparison of film and XiO depth doses for 6, 12 and 18 MeV electron 
beams for (a) 10 x 10 cm
2 
field, 100cm SSD and (b) 6 x 6 cm
2 
field, 105 cm SSD. 
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Figure 4.11 Standard field comparison of film and XiO 2-D isodose distribution (left) 
and dose difference maps (right) for 6 MeV, 12 MeV and 18 MeV, (a) 10 × 10 cm
2
 at 
100cm SSD and (b) 6 × 6 cm
2
 field at 105 cm SSD. Blue represents film lower than 
calculated XiO dose and red represents film higher than calculated XiO dose. Grid 
size is 1 x 1 cm
2
. 
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4.6.2 Obliquity measurements 
Oblique field depth dose curves are shown in figure 4.12 which compares film and 
XiO central axis depth doses at 105cm SSD for 6, 12 and 18 MeV with a 25° and 45° 
beam angle. Agreement is mostly within 2% or 2 mm beyond Dmax. However, larger 
differences are seen in the build-up region and Dmax for the 45° beam angle, where 
the XiO dose is always higher than film dose for all energies. The largest difference of 
up to 8.9% is seen for 6 MeV. The XiO dose difference is observed to decrease with 
increasing beam energy. The largest oblique field radiological width difference of 1.1 
mm was seen for the 12 MeV, 45° beam angle. Overall, the radiological widths were 
within 1 mm for all oblique fields.  
Figure 4.13 shows the comparison between film and XiO 2-D dose distribution 
and dose difference maps for 6, 12 and 18 MeV electron beam, 105 cm SSD at 25° 
and 45° incident beam angle. The isodose lines show good consistency between 
measurements and calculations. Gamma passing rates are above 90% for a 3% / 3 
mm gamma comparison criterion.  
The dose difference map shown in figure 4.13 highlights where the differences 
are and failing points lie mostly in the build-up region and Dmax. Minimal differences 
were observed at 25° incident beam angle as the gamma passing rates were well 
above 97%. However, for the 45° incident beam angle, large dose differences of up 
to 9% are seen in the build-up and Dmax region. This is indicated by the blue region in 
figure 4.13 (b) where XiO dose is higher than film dose. 
 
 
85 
 
 
 
 
 
Figure 4.12 Comparison of film and XiO depth doses for 6, 12 and 18 MeV electron 
beam with 6 x 6 cm
2 
field, 105cm SSD at a) 25° and b) 45° incident beam angle. 
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Figure 4.13 Oblique field comparison of film and XiO 2-D isodose distribution (left) 
and dose difference map (right) for 6 MeV, 12 MeV and 18 MeV, 6 × 6 cm
2
 field, 105 
cm SSD at (a) 25° and (b) 45° incident beam angle. Blue represents film lower than 
calculated XiO dose and red represents film higher than calculated XiO dose. Grid 
size is 1 x 1 cm
2
. 
87 
 
4.6.3 Small Circular fields 
Figures 4.14 and 4.15 show the comparison between film and XiO central axis depth 
doses for 2, 3 and 6 cm circular fields at 100 cm SSD for 6, 12 and 18 MeV beams. 
Overall, excellent agreement of within 1 % and 1 mm beyond the nominal Dmax is 
observed. The largest difference for small circular field measurements is again 
apparent in the build-up region up to Dmax where the dose difference of up to 5% for 
the 12 and 18 MeV beams were seen when compared to film. Overall, the film 
measured radiological widths for small circular fields were within 1 mm of XiO 
calculations. 
Figures 4.16, 4.17 and 4.18 show the 2D dose distributions and dose 
difference maps for circular fields of 2, 3 and 6 cm diameter. Overall, good 
agreement is seen for the 6 MeV, 2 and 3 cm diameter field sizes. The largest dose 
difference of up to 5% for small circular field measurements is seen for the 12 and 18 
MeV beam. Again, the differences are apparent in the build-up region, Dmax and field 
edges. In figure 4.17(c), the lowest isodose line (40 cGy) shows the largest difference 
and is illustrated by the blue regions of the dose difference map indicating that dose 
to film is lower than calculated XiO dose. In figure 4.18(b), the dose difference in the 
build-up region is seen by the red regions of the dose difference map indicating that 
dose to film is higher than calculated XiO dose. 
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Figure 4.14 Comparison of film and XiO depth doses for 6, 12 and 18 MeV electron 
beam using 2 and 6 cm diameter circular fields at 100 cm SSD. 
 
 
 
Figure 4.15 Comparison of film and XiO depth doses for 6, 12 and 18 MeV electron 
beam using 3 cm diameter circular fields at 100 cm SSD. 
 
 
0.0
0.2
0.4
0.6
0.8
1.0
0 1 2 3 4 5 6 7 8 9 10
A
b
so
lu
te
 D
o
se
 (
cG
y/
M
U
)
Depth (cm)
Film XiO
6 MeV 
2cm
12 MeV
6cm
18 MeV
6cm 
0.0
0.2
0.4
0.6
0.8
1.0
0 1 2 3 4 5 6 7 8 9 10
A
b
so
lu
te
 D
o
se
 (
cG
y/
M
U
)
Depth (cm)
Film XiO
12 MeV
3cm
18 MeV
3cm 
6 MeV 
3cm
89 
 
 
 
Figure 4.16 Small field comparison of film and XiO 2-D isodose distribution (left) and 
dose difference map (right) for 6 MeV, 2 cm diameter circular field at 100 cm SSD. 
Blue represents film lower than calculated XiO dose. Grid size is 1 x 1 cm
2
. 
 
 
 
Figure 4.17 Small field comparison of film and XiO 2-D isodose distribution (left) and 
dose difference map (right) for (a) 6 MeV, (b) 12 and (c) 18 MeV, 3 cm diameter 
circular field at 100 cm SSD. Blue represents film is lower than calculated XiO dose 
and red represents film is higher than calculated XiO dose. Grid size is 1 x 1 cm
2
. 
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Figure 4.18 Small field comparison of film and XiO 2-D isodose distribution (left) and 
dose difference map (right) for (a) 12 MeV and (b) 18 MeV, 6 cm diameter circular 
field at 100 cm SSD. Blue represents film lower than calculated XiO dose and red 
represents film higher than calculated XiO dose. Grid size is 1 x 1 cm
2
. 
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4.6.4 Inhomogeneity measurements 
Figure 4.19 shows the central axis depth dose comparison between film, XiO dose-
to-water and XiO dose-to-medium. The phantom materials of Perspex and cork that 
mimics ribs and lung are represented by the shaded areas on the depth dose curve. 
The 1 cm rib phantom is located at 1 cm depth in water followed by the 5 cm lung 
phantom. Figure 4.20 shows the central axis depth dose comparison between film, 
XiO dose-to-water, XiO dose-to-medium and “film derived” dose-to-medium. The 
Teflon material that mimics a skull is represented by the shaded area on the depth 
dose curve. The 1 cm skull phantom is located at 1 cm depth in water. Interpretation 
of the dose-to-water and dose-to-medium results is discussed in detail in chapter 5. 
Figure 4.19 shows that XiO dose-to-water and XiO dose-to-medium agrees very 
closely in most regions with the exception of within the rib phantom. Here, XiO dose-
to-medium is up to 2.5% lower than XiO dose-to-water – as would be expected with 
higher energy absorption in high density bone leading to lower absorbed dose (in the 
same volume). Within the rib, the film measurements of dose-to-water, is up to 6.6% 
lower than XiO dose-to-water. Up to 1 cm beyond the rib, the film measured dose is 
5.9% higher than XiO dose-to-water. In both of these cases, differences outside the 
uncertainty of measured and calculated doses are observed. The “film derived” 
dose-to-medium is also shown in figure 4.19 and when compared to XiO dose-to-
medium, a difference of up to 7.2% is observed within the rib phantom. In the lung 
phantom, a difference of up to 2.5% is seen between “film derived” dose-to-medium 
and XiO dose-to-medium. 
Figure 4.20 again shows very close agreement between XiO dose-to-water and 
XiO dose-to-medium in regions of water. However, larger differences are seen in the 
high density Teflon of the skull phantom. Within the bone, XiO dose-to-medium is up 
to 13% lower than XiO dose-to-water. The film measurement agrees with XiO dose-
to-medium to within the uncertainty of both measured and calculated dose in all 
regions. The “film derived” dose-to-medium is also shown in figure 4.20 and when 
compared to XiO dose-to-medium, a difference of up to 3.6% is observed at Dmax. 
Figure 4.21 shows the 2D dose distribution and Gamma dose difference maps 
for the film measurement and XiO dose-to-water results in the rib and lung and skull 
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phantoms. Film and XiO agree to within 7% inside the heterogeneities. Differences 
are predominantly near the interface between materials. These differences can be 
seen clearly on the dose difference maps in Figure 4.21.  
Finally XiO dose-to-water and XiO dose-to-medium 2D dose distributions were 
compared for the skull phantom and are shown in Figure 4.22. Overall, there is good 
agreement between the two except for the region containing the skull phantom. The 
XiO dose-to-medium within the skull phantom is 10% lower than XiO dose-to-water. 
The Gamma criterion is set to 3%/3 mm. Figure 4.22 also shows the Gamma dose 
difference map where the blue regions indicate that dose-to-medium is lower than 
dose-to-water. 
 
 
 
Figure 4.19 Comparison of XiO dose-to-medium, XiO dose-to-water and film and 
“film derived” dose-to-medium depth doses in the rib and lung phantom for a 6 
MeV 10 x 10 cm
2 
field at 100 cm SSD. 
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Figure 4.20 Comparison of XiO dose-to-medium, dose-to-water, film and “film 
derived” dose-to-medium depth doses in the skull phantom for a 6 MeV 6 x 6 cm
2 
field at 100 cm SSD. 
 
Figure 4.21 Comparison of  2-D dose distributions (left) and dose difference maps 
(right) for film and XiO dose-to-water for (a) rib and lung phantom (shaded blocks) 
irradiated with a 6 MeV, 10 × 10 cm
2
 field at 100 cm SSD, and (b) skull phantom 
(shaded block) irradiated with 6 MeV, 6 × 6 cm
2
 field at 100 cm SSD. Blue represents 
film is lower than calculated XiO dose and red represents film is higher than 
calculated XiO dose. Grid size is 1 x 1 cm
2
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Figure 4.22 Comparison of calculated 2D dose distribution (left) and dose difference 
map (right) for XiO dose-to-water and XiO dose-to-medium in the skull phantom for 
a 6 MeV 6 x 6 cm
2 
field at 100 cm SSD. Blue indicates the XiO dose-to-medium is 
lower than XiO dose-to-water. Grid size is 1 x 1 cm
2
. 
  
4.7 Measurement summary 
A summary of the comparison metrics between calculated XiO and measured EBT3 
film for all fields are shown in Table 4.1. Gamma analysis was performed for all fields 
using gamma pass criteria of 2% or 2 mm for standard fields and 3% or 3 mm for the 
oblique, circular and inhomogeneity fields. The gamma criteria align with 
recommendations stated in TRS 430 (IAEA, 2004). The dose difference at Dmax was 
observed to be within ±2% for standard fields, ±8.9% for oblique fields, ±4.7% for 
circular fields and ±3.2% for inhomogeneity measurements. Overall, the distance to 
agreement (DTA) at depths of R90 and R50 were within 2 mm with the largest 
difference observed in the inhomogeneity measurements. The radiological width 
(RW50) of the profile at the depth of Dmax agreed to less than 1.6 mm with the largest 
error observed at extended SSD measurements.  
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Table 4.1 Comparison of EBT3 film to XiO for all measured fields. 
 
 
 
Measurement SSD Applicator Setup Energy 
Gamma 
passing rate 
Dmax Dose 
difference 
R90 
DTA 
R50 
DTA 
RW50 
difference 
(Gamma criteria) (cm) (cm
2
)   (MeV) (%) (%) (mm) (mm) (mm) 
Standard Fields 105 6x6 0° 6 96.4 -2.0 0.1 0.7 1.6 
(2%, 2 mm)    12 93.6 0.3 0.1 0.0 1.3 
    18 94.4 -0.9 0.3 0.4 1.3 
 100 10x10 0° 6 99.7 -0.6 0.1 0.3 0.5 
    12 96.2 -0.8 0.6 0.3 1.1 
        18 85.6 -1.7 1.2 0.0 1.5 
Oblique Fields 105 6x6 25° 6 100.0 -0.7 0.8 0.1 0.9 
(3%, 3 mm)    12 99.5 1.1 0.6 0.8 0.6 
    18 97.3 1.2 1.2 0.2 0.8 
   45° 6 90.4 -8.9 0.3 0.6 0.9 
    12 94.9 -5.0 0.6 0.5 1.1 
        18 97.1 -3.3 1.2 0.6 0.2 
Circular Fields 100 6x6 2 cm 6 99.2 -0.2 0.4 0.3 0.6 
(3%, 3 mm)   3 cm 6 98.4 4.0 0.6 0.1 0.5 
    12 92.8 4.7 0.3 1.1 0.4 
    18 98.1 2.5 0.0 0.1 0.8 
   6 cm 12 99.6 -2.5 0.6 0.8 1.0 
        18 87.6 2.2 0.0 1.3 0.4 
Inhomogeneity 100 10x10 Rib/lung 6 99.1 -6.6 2.0 1.3 1.2 
(3%, 3 mm)    6x6 Skull 6 98.1 2.1 0.0 0.3 0.0 
96 
 
DISCUSSION 
5.1 Film method 
This study has resulted in the development of a method for high resolution 2D film 
measurement in a portable water phantom. Electron beam parameters such as R90, 
R50 and RW50 can be determined accurately with this method. If an ionisation 
chamber is used, the depth ionisation must be converted to depth dose as 
recommended by TRS 398 (IAEA, 2000). This conversion is required in electron 
beams because the water to air stopping-power ratios changes rapidly due to the 
differences in energy spectra with depth (IAEA, 2000). The conversion is not 
necessary with radiochromic films because the stopping power ratio between water 
and film is close to 1 and is less sensitive to changing electron spectrum.  
The film measurement method described in this study has its benefits over 
conventional ionisation chambers and other types of array detectors. When 
compared to ionisation chambers, films offer a relatively higher 2-D spatial 
resolution and can be used in high dose gradient regions. Ionisation chambers have a 
fixed collecting volume for cylindrical chambers and fixed separation for plane 
parallel chambers which limits the resolution. When scanned with a flatbed scanner, 
films can provide sub-millimetre spatial resolution.  
The presence of ionisation chambers during measurements perturbs the beam 
and to account for these perturbations, corrections like cavity, displacement, side 
wall and central electrode as described in TRS398 (IAEA, 2000) are required. Other 
factors that affect ionisation chamber measurements in electron beams include stem 
and cable effects, chamber polarity, ion recombination and chamber depth offset 
correction. Films on the other hand are very thin and cause minimal perturbation. 
The charge collected in an ionisation chamber of any type depends upon the 
electron fluence in the active volume of the chamber. For normal incident beams, 
the electron fluence across the chamber is uniform with minimal perturbation. 
However, ionisation chambers tend to over-respond at depth for beams which are 
obliquely incident. This is due to increased scatter in the sidewall of the chamber 
into the active volume (Gerbi and Khan, 1997). This is illustrated in figure 5.1 which 
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shows the path of the electrons passing through the chamber side wall for an 
obliquely incident beam. For obliquely incident beam measurements with films, the 
over-response in dose is not seen. The difference in stopping power ratios between 
air and water for ionisation chambers is not relevant for film. The difference in 
stopping power between film and water is negligible therefore the over-response in 
dose is not seen in films. 
 
Figure 5.1 Diagram illustrating the electron path passing through the chamber side 
wall resulting in an increase in scatter contribution. Figure reproduced from 
(Ostwald, 1998). 
 
 
Figure 5.2 Depth ionisation curves for (a) 6 MeV and (b) 12 MeV for a 6 x 6 cm
2
 field. 
Depth ionisation is measured along the central axis of the beam at 0, 15, 30, 45 and 
60°. Figure reproduced from (Biggs, 1984). 
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The dose increase due to beam obliquity for small fields was investigated by 
Biggs (Biggs, 1984) using a thin window, parallel-plate ionisation chamber (SHM 
Nuclear Corporation, Sunnyvale, CA). Figure 5.2 shows measured depth ionisation 
curves taken along the beam axis for energies of 6 and 12 MeV at 0°, 15°, 30°, 45° 
and 60°. The plot displays an increase in surface dose as the beam angle increases 
for the 6 MeV curve. Similar differences were observed in this study. Figure 5.3 
shows the EBT3 film measured depth dose curve for (a) 6MeV and (b) 12 MeV 
electron beam with 6 x 6 cm2 field, 105cm SSD at beam angles of 0°, 25° and 45°. The 
depth dose curve is taken normal to the water surface and was normalised to Dmax to 
provide a relative comparison to the data presented by Biggs (Biggs, 1984). Biggs’ 
data shows an increase of less than 5% of the surface dose for the 6 MeV beam 
when the angle of incidence is varied from 0° to 60°, as measured with a parallel-
plate ionisation chamber. However, for the 6 MeV beam measured in this study, 
surface doses measured by EBT3 film shows an increase of up to 9% when the angle 
of incidence is varied from 0 to 45°.  
The problems with the use of parallel plate ionisation chambers for measuring 
surface doses for obliquely incident electron beams has been discussed above (Biggs, 
1984; Ostwald and Kron, 1996). The film method used in this work is not subject the 
geometry issues that affect ionisation chambers and therefore may provide a better 
reference for validating XiO calculated data. Film has been shown to agree to within 
3% with both ionisation chamber and XiO for normally incident beams and would be 
expected to measure dose for other geometries with the same degree accuracy.  
Closer inspection of the data used in this work shows that XiO predicts an 
increase in surface dose of 11% as the beam angle increases from 0° to 45° for the 6 
MeV beam. This agrees well with the increase in surface dose measured with film. 
However, the XiO surface doses are higher than film for the most oblique angles, as 
will be discussed in section 5.2. 
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Figure 5.3 EBT3 film measured depth dose curve normalised to Dmax for (a) 6 MeV, 
(b) 12 MeV and (c) 18 MeV electron beam with 6 x 6cm
2 
field, 105cm SSD at beam 
angles of 0°, 25° and 45°. 
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Figure 5.4 Variation of percent surface ionisation with angle of incidence of the 
electron beam. Figure reproduced from (Biggs, 1984). 
 
Figure 5.4 shows the variation of surface ionisation with angle of incidence 
measured by Biggs (Biggs, 1984) using a parallel-plate ionisation chamber for 
different energies. The reported results state that the surface ionisation increase 
relatively as oblique incident angle increases for electron energies below 9 MeV. For 
9 and 12 MeV, the difference is very minimal and at energies above 12 MeV, surface 
dose decreases slightly with increasing beam angle. The increase in surface dose 
with beam angle for the lower energies and slight decrease in surface dose at the 
higher energies is also seen with data measured by EBT3 film as shown in figure 5.3. 
Conventional dosimetry equipment, such as Farmer ionisation chambers and 
plane-parallel chambers, are not suitable for use in small electron field 
measurements due to the loss of lateral electronic equilibrium and partial volume 
irradiation effects (Podgorsak, 2005). Radiation detectors introduced into small fields 
usually perturb the level of disequilibrium which affects the accuracy of dose 
determination (Das et al., 2008b). With a large variety of radiation detectors, the 
choice of a suitable detector for small field dosimetry could be a challenging task. 
Although radiation detectors such as diodes, TLDs and MOSFETs have their 
advantages in small field dosimetry, radiochromic film could provide superior 
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advantages through its characteristics. Radiochromic film is able to provide the 
highest spatial resolution, absolute dosimetry and planar dose validation at the same 
time. Radiochromic films, Gafchromic® in particular, have previously  been limited to 
relative dosimetry (McLaughlin et al., 1994), but this study demonstrated that 
absolute dosimetry with the newer version of Gafchromic® EBT3 film is possible. 
Although film dosimetry provides a huge advantage over conventional 
dosimetry equipment for non-standard field measurements, it has some 
weaknesses. Absolute dosimetry with radiochromic films requires post-exposure 
timing. To ensure accurate results, calibration and measurement films must be 
scanned at known times after exposure (Lewis, 2012). The orientation of the film 
must be noted especially for calibration films where the films are cut into smaller 
pieces. During the scanning process, the orientation of the film must be consistent 
for all scans. Differences of up to 9% are seen when comparing portrait and 
landscape scanning orientations (Andres et al., 2010). In this work, the films’ 
orientation was marked so that they can be consistently placed on the scanner bed. 
All films were placed in the centre of the scanner bed to minimise scanner non-
uniformity effects. 
This study demonstrated that accurate absolute dosimetry is possible with 
radiochromic film using a commercial flatbed scanner. However, care must be taken 
to minimise any inherent errors that may arise from either film and/or the scanner. 
Dose calibration films have to be done in conjunction with the measurement film to 
properly characterise the conversion from optical density to absolute dose. This is 
done by determining the linear accelerator output and the known dose is delivered 
to each calibration film. The absolute dose accuracy of radiochromic film when 
compared to ionisation chambers has been previously reported to be within 2% - 4% 
(Chung et al., 2010). This study shows similar results where the agreement between 
EBT3 film and PPC05 absolute depth dose was within 3%. 
The excellent agreement between film and ionisation chamber measurements 
for a number of standard fields, gives confidence in the accuracy of the film method. 
It has allowed the validation of the XiO eMC algorithm to be extended to include 
more complex field geometries. These include inhomogeneous geometries typical of 
those found in patients requiring electron therapy. 
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5.2 Comparison of EBT3 film and XiO eMC 
In order to speed up the calculation times, eMC applies several simplifications and 
approximations to the electron transport algorithm. The main approximations are 
the reduction of the number of histories and average number of electron steps per 
history, the exclusion of photon contribution during simulation, the approximations 
for the Bremsstrahlung, Møller cross sections and treatment of delta rays, and the 
simplified multiple scattering distribution (Kawrakow et al., 1996). Among the 
approximations made, the Bremsstrahlung approximations, the treatment of delta 
rays and the simplified multiple scattering could potentially explain observed 
differences between XiO calculated dose and film for the fields investigated in this 
work. In addition to the uncertainties in XiO, the uncertainties in film dosimetry such 
as the film response, changes to electron spectrum and some angular dependence of 
the film response could be a contributing factor to these observed differences.  
The simplification of Bremsstrahlung photon modelling in the linear 
accelerator introduces errors in the calculation but at energies used for radiation 
therapy, the contribution of Bremsstrahlung to the dose deposited in the patient is 
small and only significant for higher energy beams in the low dose tail at large 
depths. There are low energy X-ray contaminations produced by the electron 
scattering foil in the linear accelerator that reach the patient surface and also 
contribute to dose in the patient. For an accurate dose calculation, a full simulation 
of every incident electron should be performed. However, this can be 
computationally time consuming, so approximations are made to speed up the 
process. One such approximation in XiO eMC is that the photon background is 
extracted from a measured dose distribution in a water phantom, and then it is 
added to the eMC calculated dose distributions as a constant contribution. This 
approximation is valid for standard beam field size and geometry, but with complex 
treatment geometries, the photon background contribution may vary and is not as 
accurate.    
Delta rays are secondary electrons created by energy transfer to the atomic 
electron. In the eMC model, the production of delta rays is modelled using an 
approximation of the Møller cross section which utilises the cut-off energy, rejecting 
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delta rays below an energy threshold. In the build-up region, where the electron 
energy is at its highest, the assumption that delta rays deposit their dose where they 
are created has a small or negligible effect. This is apparent as the dose calculated by 
XiO near the surface agrees very well with film for normally incident beams. 
Beyond Dmax, the agreement between EBT3 film and XiO eMC was 2% or 2 mm 
for standard fields and 3% and 3 mm for the oblique, small and fields with 
inhomogeneities. Beyond Dmax, the central axis depth dose profiles show good 
agreement between measured and calculated doses of less than 3%/2 mm in all 
cases. The 2D isodose distributions show that the largest difference between 
measured and calculated dose is seen for the low isodose lines. This can be seen in 
figures 4.11, 4.13, 4.16, 4.17 and 4.18 where majority of the differences fall at the 
field edge. Of all the energies used in this study, 18 MeV was found to have the 
poorest agreement between EBT3 film and XiO eMC for the standard fields. Here 
differences of up to 3% are seen in the region between 3 and 5 cm depth, as shown 
in figure 4.10 (a). This data is shown again in figure 5.5 where it can be seen that the 
difference is within the measurement uncertainty of ±3% (2σ).  
 
 Figure 5.5 Comparison of EBT3 film and XiO eMC depth doses for 18 MeV electron 
beam for 10 x 10 cm
2 
field, 100 cm SSD. The region between 3 and 5 cm depth is 
shown in the insert figure. Error bars are ±3% (2σ) for film and ±2% (2σ) for XiO. 
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In the dose difference maps, the blue regions indicate EBT3 film measurements 
are lower than XiO eMC and red regions indicate that EBT3 films are higher than XiO 
eMC. During the comparisons, an automatic registration was performed which was, 
if necessary, followed by a manual match of up to 1 mm, so that the highest gamma 
passing rate was achieved. If the red or blue regions appear on opposite sides of the 
measurement, this generally indicates that there may be an alignment error, shifts of 
1 mm in the X direction was performed to ensure that the best match is obtained. 
The difference seen at the field edges is a result of the steepness of the field edge 
gradient and the SNC Patient software limitation which allows a minimum shift of ±1 
mm and this also contributed to the lateral asymmetry. Nevertheless, the 
discrepancies between EBT3 film and XiO eMC are still within the acceptance criteria 
based on the IAEA TRS 430 report (IAEA, 2004).  
For oblique fields, the DTA for measured and calculated central axis depth 
doses is less than 1.2 mm at depths beyond Dmax. The largest difference of 8.9% is 
seen in the build-up region for the 6 MeV 45° beam as shown in Figure 4.13 (b). 
Figure 5.6 shows the comparison of EBT3 film and XiO for this 6 MeV beam again but 
with error bars showing the uncertainty for both measured and calculated dose. 
Beyond 0.7 cm depth EBT3 film and XiO eMC agree to better than ±3 % i.e. within 
the expected uncertainties. However, differences of up to 8.9% are seen from the 
surface to 0.7 cm depth which are outside the expected uncertainties and may 
indicate a limitation of the XiO model. 
For small fields, the DTA between measured and calculated central axis depth 
doses is less than 1 mm beyond Dmax. For 12 and 18 MeV, differences of up to 5% are 
seen from the surface up to Dmax for the 3 cm fields as shown in Figure 4.15. The 
difference in the first few millimetres is likely due to calculation grid size effects as 
the XiO dose is constant over this region. The difference from 0.3 cm up to Dmax is 
due the limitations of XiO eMC modelling small field sizes, resulting from the use of 
pre-calculated kernels as discussed in Section 2.4.3. Because of these inaccuracies, 
the model has not been released for clinical use at field sizes less 6 cm diameter. For 
the 6 cm field, large differences are seen for 18 MeV near the surface as shown in 
Figure 4.14. Figure 5.7 shows this data again comparing XiO eMC and EBT3 film, with 
error bars showing the uncertainty for both measured and calculated dose. Beyond 1 
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cm depth, XiO eMC and EBT3 film agree to better than 3% i.e. within the expected 
uncertainties. However, larger differences are seen from the surface to 1.0 cm depth 
which are outside the expected uncertainties and may indicate a limitation of the 
XiO model.  
 
 
Figure 5.6 Comparison of film and XiO depth doses for 18 MeV electron beam with 6 
x 6 cm
2 
field, 105 cm SSD at 45° incident beam angle. The region from the surface to 
1 cm depth is shown in the insert figure. Error bars are ±3% (2σ) for film and ±2% 
(2σ) for XiO. 
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Figure 5.7 Comparison of film and XiO depth doses for 18 MeV electron beam using 
6 cm diameter circular field at 100 cm SSD. The region between the surface and 2.5 
cm depth is shown in the insert figure. Error bars are ±3% (2σ) for film and ±2% (2σ) 
for XiO. 
 
The largest differences between EBT3 film and XiO eMC occur in the build-up 
region for both obliquely incident and small field beams. A possible explanation for 
this observation is that whilst the approximations used for multiple scattering are 
adequate to predict dose for standard beam configurations, they may be insufficient 
to accurately predict dose in more complex geometries. For obliquely incident 
beams, wide angle scatter would result in electrons “escaping” from the phantom. 
Failure to account for these “lost” electrons would mean that the dose deposited in 
the phantom would be overestimated by the model and the calculated dose would 
be expected to be higher than the measured dose. This is what was observed in this 
work. Similarly, for small, normal incidence beams, large angle scatter would 
contribute to dose closer to the surface of the phantom. If this is not modelled by 
XiO, the calculated dose in this region would be lower than the measured dose. XiO 
eMC uses precomputed EGSnrc (Kawrakow et al., 2002) kernels to model the 
applicator cut-outs. The dose differences at shallow depth for both obliquely 
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incident and small field beams may be a contribution of approximations used in 
modelling scatter from the applicator cut-out.  
Comparison of EBT3 film and ionisation chamber for standard fields showed 
excellent agreement, indicating that the EBT3 film response to the broadly varying 
electron spectrum has a minimal effect on the measurement. Following on from this, 
the film response would be expected to be similarly accurate for electron spectral 
variations in non-standard fields, and inhomogeneous media. Whereas the XiO eMC 
model needs to predict changes not only in electron energy, but also the effect of 
oblique incidence, large angle scatter and calculation of dose in heterogeneous 
media. As described above, Monte Carlo is subject to deficiencies when predicting 
dose in more complex geometries whereas EBT3 film only has to deal with the 
changing electron spectrum. Hence, the observed differences for non-standard fields 
and inhomogeneous media are more likely to represent XiO eMC underestimating 
the measured EBT3 film doses.  
In figure 4.19, the central axis depth dose profile is up to 6.6% lower than XiO 
within the rib. This can also be seen in the isodose lines near central axis in the 2D 
dose comparison in Figure 4.20 (a). The agreement between measured and 
calculated isodose lines in the outer ribs is significantly better than at central axis. 
The reasons for this difference may be related to the difficulty in setting up the 
phantom and a lack of adhesion of the rib and lung phantom to the film at central 
axis. The depth dose profiles through the outer ribs show better agreement than at 
central axis. Figure 5.8 (a) shows the same comparison as figure 4.19 at 2 cm off 
beam central axis in the cross-plane direction. The film measurement here shows 
better agreement with XiO than on central axis. At 1 cm beyond the rib, in the lung, 
the difference between XiO eMC and EBT3 film is less than 1%. To compare film to 
XiO in the rib, the film derived dose-to-medium is compared to XiO dose-to-medium 
as outlined in section 3.10.4. This data is shown in Figure 5.8 (b) with error bars 
showing the uncertainty in both measured and calculated data. Differences of up 
10% are seen within the rib which is outside the expected uncertainties even when 
taking into account the added uncertainty of the film dose conversion. This result 
may indicate a limitation in the XiO modelling or the approximations made in the 
film conversion. Or it may be a result of the difficulty in setting up the phantom. At 1 
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cm beyond the rib, in the lung, differences between film and XiO are within the 
expected uncertainties. 
 
 
 
Figure 5.8 (a) Comparison of XiO dose-to-medium, XiO dose-to-water, film and film 
derived dose-to-medium depth doses in the rib and lung phantom for a 6 MeV 10 x 
10 cm
2 
field at 100 cm SSD. Depth dose profiles are taken at 2 cm off beam central 
axis. XiO dose-to-medium and film derived dose-to-medium comparison with error 
bars are shown in (b). The insert figure shows the region between 1 and 2 cm depth.  
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Figure 4.20 shows that dose to film agrees with XiO dose-to-water to within 
the measurement and calculation uncertainties for the skull phantom. Figures 4.19 
and 4.20 both show that as density increases, a larger disparity is observed between 
the calculated dose-to-water and dose-to-medium. Calculated dose-to-medium is 
lower than dose-to-water for bone, as expected as mass collision stopping power for 
bone is less than equivalent density water (refer to section 5.3 for detailed 
explanation). 
The XiO eMC dose-to-medium depth dose curve would be expected to have 
the same value as the XiO eMC dose-to-water depth dose in the water region before 
and beyond the interfaces of the skull phantom. As seen in figure 4.20, the XiO doses 
agree very closely in this region. The small discrepancy between the XiO dose-to-
medium and dose-to-water curves near the proximal bone interface is likely due to 
the limited spatial resolution of the calculation grid size and interpolated values 
when plotting the data points. In figure 4.20, XiO eMC calculated doses were seen to 
be higher than the film measured and derived doses in the region beyond the skull. 
The reason for this discrepancy was investigated further.  
This measurement was repeated recently on the new linear accelerator which 
is matched to the one used in this work. The recent measurement (figure 5.9 (a)) 
shows much better agreement between EBT3 film and XiO eMC in and beyond the 
region of the skull. In addition, the recent measurement shows the EBT3 film doses 
are higher than the XiO eMC doses in the Bremsstrahlung tail which is consistent 
with the results in figure 4.6 as discussed in 4.3.1 above. Figure 5.9 (b) shows only 
the film derived dose-to-medium and XiO dose-to-medium with error bars, and that 
the differences between EBT3 film and XiO eMC are within the expected 
uncertainties. 
Initially only one measurement was done for each of the inhomogeneous set-
ups, due to difficulty of positioning of the film and phantom materials in the water 
phantom. However, these measurements should have been repeated at the time to 
establish the reproducibility of the set-up. 
The XiO eMC conversion from dose-to-medium to dose-to-water is not 
accurately calculated, as discussed below, so a meaningful comparison of XiO eMC 
with EBT3 film is not currently possible for the inhomogeneous set-ups. 
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Figure 5.9 (a) Comparison of XiO dose-to-medium, XiO dose-to-water, film and film 
derived dose-to-medium depth doses in the skull phantom for a 6 MeV 10 x 10 cm
2 
field at 100 cm SSD. Depth dose profiles are taken at beam central axis. XiO dose-to-
medium and film derived dose-to-medium comparison with error bars are shown in 
(b). The insert figure shows the region between 1 and 2 cm depth. 
 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0 1 2 3 4
A
b
so
lu
te
 D
o
se
 (
cG
y/
M
U
)
Depth (cm)
XiO dose-to-medium
XiO dose-to-water
Film
Film derived dose-to-medium
WaterWater Scalp 
Phantom
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0 1 2 3 4
A
b
so
lu
te
 D
o
se
 (
cG
y/
M
U
)
Depth (cm)
XiO dose-to-medium
Film derived dose-to-medium
WaterWater
Scalp 
Phantom
0.2
0.4
0.6
0.8
1.0
1 2
(b) 
(a) 
111 
 
5.3 Dose-to-water vs Dose-to-medium 
Monte Carlo (MC) based treatment planning systems (TPS) are often based on 
simpler models than those implemented in general MC codes, but still provide a 
better dose distribution than those obtained using traditional analytical algorithms. 
Traditional dose calculation algorithms have always assumed that patient tissues can 
be treated as water-like, so tissues with high densities, such as bone, are modelled 
as high density water. Conversely, tissues such as lung are modelled as low density 
water. In XiO eMC, the density information is extracted from Computed Tomography 
(CT) scans by using the Hounsfield (HU) numbers to look up the electron density (ED) 
on a voxel by voxel basis. 
The Monte Carlo dose calculation algorithm is based on the actual elemental 
composition of tissues, which takes in to account differences in absorption 
properties. A CT scan is used to determine electron densities of each voxel and 
assign material compositions to that voxel based on its HU. Unlike conventional dose 
calculation algorithms that use water with different electron density to account for 
the effect of patient heterogeneous anatomy, Monte Carlo calculates the energy 
deposition in different tissue types and reports dose to medium. 
The AAPM Task Group 105 recommended that Monte Carlo results should 
allow conversion between dose-to-medium and dose-to-water, based on Bragg-Gray 
cavity theory (Chetty et al., 2007). The reason for the conversion is to provide a 
comparison for MC algorithms with conventional dose-to-water algorithm (Siebers et 
al., 2000). The conversion from dose-to-medium to dose-to-water or vice-versa, 
involves multiplying the energy deposited by primary and secondary electrons for 
each electron energy  step  by the ratio of restricted mass collision stopping powers 
of water to local medium for the current energy of the electron (Siebers et al., 2000). 
Figure 5.10 shows the mass collision stopping power as a function of tissue density 
for different electron beam energies. The mass collisional stopping power ratios 
show that dose to bone is lower when calculated as dose to medium, and similarly 
dose to lung is slightly higher, than when calculated as dose to equivalent density 
water.  
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Figure 5.10 Mass collision stopping power divided by the mass collision stopping 
power of water as a function of density normalised to water. A comparison fit of the 
function to the ICRU data for body tissues for electron energies of 5, 15 and 30 MeV 
is shown. Figure reproduced from (Kawrakow et al., 1996). 
 
The conversion from dose-to-medium to dose-to-water has been investigated 
by a number of authors and the magnitude of the differences between dose-to-
medium and converted dose-to-water in published reports are 1% for soft tissue and 
10% for cortical bone (Siebers et al., 2000). The differences between the two 
methods are shown in figure 4.22 and have clearly been shown in other publications 
(Dogan et al., 2006; Knoos et al., 2006; Ma et al., 1999) which use the same method 
for converting from dose-to-medium to dose-to-water. Figure 5.11 shows a clinical 
example comparing dose-to-medium and dose-to-medium converted to dose-to-
water for an electron chest-wall patient plan. The top image shows the dose 
distribution for dose-to-medium and middle image shows converted dose-to-water. 
The bottom image shows difference between dose-to-medium and converted dose-
to-water. It becomes obvious that dose in bone appears to be lower (blue regions) 
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and dose in lung appears to be higher (red regions) when dose-to-medium is 
compared to converted dose-to-water.  
The implementation of dose-to-medium may result in a change in clinical 
practice as the calculated dose per MU may differ significantly from that calculated 
using more traditional methods. Care must be taken to understand the impact of 
changing to a Monte Carlo algorithm and to quantify the potential impact on 
delivered dose to the patient.  Any changes in clinical practice, i.e. treatment MU, 
must be discussed with radiation oncologists prior to treatment. Based on figure 
5.11, if beam reference point in bone, and dose to medium is used to calculate dose, 
the monitor unit could be as much as 10% higher than what would have been used 
in traditional algorithms. 
In this project, some comparisons were done in water where differences 
between dose-to-medium and dose-to-water are insignificant. However, when 
inhomogeneities are introduced, both dose-to-medium and converted dose-to-water 
calculations were used for comparison. There are two possible options to simulate 
both film and the inhomogeneous media. The first option is to create a phantom in 
XiO with a 280 µm thick slab with a relative electron density of 1 to simulate EBT3 
film. However, it is not possible to calculate dose for a 280 µm grid size. The other 
option, which is used in this project, is to create a phantom with bone and 
surrounding water and calculate both dose-to-medium and dose-to-water for 
comparison with film, taking into account that dose-to-water overestimates the dose 
because of the limitation on converting dose-to-medium back to dose-to-water, as 
discussed below. 
Current commercial Monte Carlo algorithms do not calculate the conversion 
from dose-to-medium to dose-to-water accurately. The algorithm does not re-
calculate the dose distribution via Monte Carlo using water as the medium.  The 
conversion employs methods that utilise stopping power ratios and ignore 
differences in fluence for water-like and tissue-like media (Andreo, 2015). To 
demonstrate the issue, a water phantom was created in XiO and the dose at Dmax 
was calculated using a 10 x 10 cm2 field at 100 cm SSD for 6, 12, and 18 MeV. The 
entire phantom was forced to varying electron density and re-calculated. The result, 
as can be seen in Figure 5.12, is the converted dose-to-water will be overestimated 
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for tissues with a density greater than water. In soft tissues, ignoring the fluence 
correction is not significant.  
Given that Monte Carlo calculations are determining dose-to-medium, there 
are two possibilities when comparing film measurements to XiO eMC calculations. 
One can compare film-derived dose-to-medium directly with XiO dose-to-medium. 
For water phantom measurements, the medium is water and this comparison is 
valid. For other densities, which are translated by XiO into a selection of different 
media, this is more difficult as film is calibrated as dose-to-water (where 
heterogeneous media is simply scaled by density). The other alternative would be to 
convert dose-to-medium as calculated using Monte Carlo to dose-to-water. Most 
planning systems allow this. Unfortunately, this process is affected by significant 
uncertainties and a recent article by Andreo, P. (Andreo, 2015) discusses these in 
great depth. The journal ends with the recommendation that these conversions 
should be avoided. The present thesis follows this rationale and compares dose-to-
medium calculated with the EBT3 film rather than to compare EBT3 film to XiO 
eMC’s dose-to-water which has not been validated. The uncertainties with either 
method of conversion, XiO dose-to-medium to dose-to-water, or film dose-to-water 
to dose-to-medium, are both subject to significant approximations. It is understood 
that the conversion method used here is an approximation, but it is believed that it 
serves as a useful and somewhat qualitative validation of XiO eMC dose-to-medium 
in heterogeneous regions, in the absence of full Monte Carlo simulation. 
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Figure 5.11 XiO eMC chest-wall plan showing 2D colourwash isodose distribution of 
calculated dose-to-medium (top) and converted dose-to-water (middle). The 
difference between dose-to-medium and dose-to-water is shown at the bottom 
image. 
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Figure 5.12 Comparison of dose per monitor unit with different electron densities 
between XiO dose-to-medium and XiO converted dose-to-water for a) 6MeV, b) 12 
MeV and c) 18 MeV.  
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CONCLUSION 
6.1 Summary 
This thesis reports on the evaluation of XiO electron Monte Carlo dose calculation 
algorithm using radiochromic films vertically submerged in a water phantom. 
Measurements were performed for energies of 6, 12 and 18 MeV for various 
standard fields and complex treatment-like geometries such as beam obliquity, small 
field sizes and tissue inhomogeneities. The films were calibrated to provide absolute 
dose per monitor unit for direct comparison with XiO electron Monte Carlo dose 
distribution. The SNC Patient software was used to compare the overall 2D dose 
distribution and the differences were quantified by gamma analysis and DTA tools. 
The uncertainties associated with the film measurement method were analysed and 
the total uncertainty was found to be ±3% (2σ). 
Beyond Dmax, XiO eMC and EBT3 film agree within the calculation and 
measurement uncertainties i.e. ± 3% or ± 2 mm for all standard, oblique and circular 
fields for measurements in water. Differences of up to 9% occur close to the surface 
for the oblique and circular fields. For the inhomogeneous media, agreement 
between XiO eMC and EBT3 film was also within the calculation and measurement 
uncertainties for the water and lung like regions. Within the rib phantom, XiO eMC is 
up to 10% higher than EBT3 film. By contrast, the agreement between XiO eMC and 
EBT3 film within the denser skull phantom is within the expected uncertainties.    
The limitations of film dosimetry have been discussed and the differences in 
dose between XiO eMC and EBT3 film could be due to deficiencies in either the eMC 
algorithm or in the film methods. However, it has been acknowledged by the 
manufacturer (Elekta) that it is very difficult to model the scatter of low energy 
electrons accurately. As low energy electrons will deposit their energy at shallow 
depths, we would therefore expect the accuracy of XiO eMC to be poorer at shallow 
depths. The EBT3 film results that show poorer agreement with XiO eMC at shallow 
depths are therefore not unexpected (J. Satterthwaite 2016, personal 
communication, 19 November) and are more likely to indicate a deficiency with XiO 
eMC rather than EBT3 film. 
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Validation of the XiO eMC algorithm for non-standard fields and 
inhomogeneous materials has been made possible by the development of a novel 
method for EBT3 film dosimetry. This study has resulted in the development of a 
method for high resolution 2D film measurements in a portable water phantom. The 
excellent agreement between film and ionisation chamber measurements for a 
number of standard field, gives confidence in the accuracy of the film method. It has 
allowed the validation of the XiO eMC algorithm to be extended to include more 
complex field geometries. These include inhomogeneous geometries typical of those 
found in patient requiring electron therapy. The method is not restricted to electron 
treatments and could be used for other situations where accurate, high resolution 
measurements are required, for example validation of small photon fields used for 
stereotactic and stereotactic ablative body radiotherapy (SABR) treatments. 
 
6.2 Clinical recommendations 
In this research, potential areas of concern are raised and clinically specific 
recommendations were made.  
The increase in surface dose as a result of highly oblique beam angles may be 
clinically significant. The doses to the skin may be overestimated by the treatment 
planning system. However, treatments with highly oblique angles are rarely given to 
patients but may be unavoidable in regions with sharp skin contour changes.  
XiO eMC calculations and measurements for small field sizes were investigated 
and eMC algorithm can accurately predict depth doses and isodose distributions for 
field sizes as small as 3.0 cm diameter for the lower beam energies and 6.0 cm for 12 
MeV and above. If a diameter of less than 3 cm is used, output factor, depth dose 
and isodose distribution should be measured.  
Due to the dose difference in the build-up region, the placement of the beam 
weight point should be taken into consideration. The beam weight point should be 
defined at the nominal Dmax for each beam energy, away from air cavities, bone and 
metal interfaces, where the dose is more accurately defined. 
This work also highlights the potential for significantly changing the actual dose 
delivered to patients if dose to medium is calculated rather than dose to water. Dose 
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to medium is inherently calculated by Monte Carlo and is believed by some (Liu et 
al., 2002; Ma and Li, 2011) to have more clinical relevance than historically used 
dose-to-water. The conversion from dose-to-medium to dose-to-water is not 
accurate in most treatment planning systems (Andreo, 2015) and can introduce 
additional uncertainty. This however has very little impact for most water-like tissues 
such as muscle and lung.  
The difference between dose to water and dose to medium calculations for the 
inhomogeneous geometries is an important issue. There is still debate in the medical 
physics community about which of these methods is most appropriate (Liu et al., 
2002; Ma and Li, 2011). Users need to be aware of these differences if dose-to-
medium is used for patient calculations. For example, if the dose was prescribed to a 
point within the skull, the treatment MUs would be approximately 10% higher using 
dose to medium compared to dose to water. This could result in a clinically 
significant change to the dose being delivered to the patient. The most recent 
recommendations, ICRU 71 (ICRU, 2004), advise that dose variations within the 
target volume of an electron treatment should be less than ±10%. 
 
6.3 Scope and limitations 
The evaluation of XiO eMC calculations was performed using radiochromic film 
measurements for 6, 12, and 18 MeV beams. The calibration curves were generated 
in SNC Patient software using the red channel for doses ranging from 10 cGy to 600 
cGy. Due to film variation between different boxes, the calibration curve is limited to 
the batch it is from. Each time a new EBT3 film box is used, a new calibration curve 
will have to be established. 
The eMC module in XiO treatment planning system uses a beam model based 
on water tank measurements. The models were generated for a Varian 21iX linear 
accelerator. Simulations were performed for various beam irradiation setups in a 
water phantom. The eMC algorithm calculates dose in a voxel at a resolution of 0.2 x 
0.2 x 0.2 cm3. The mean relative statistical uncertainty of 1% was used during 
simulations. Ideally a 0.5% uncertainty was the preferred choice but the calculation 
times were extensive due to hardware limitations of the computers used. 
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The film absolute dosimetry method developed in this project show excellent 
agreement between eMC calculations and measurements. Most standard field 
measurements obtained a 3%/2 mm agreement with eMC calculations. Agreement 
of 3%/2 mm was seen between measurement and calculations for the 25° oblique 
fields. However, at the 45° oblique beam angle, some discrepancies are observed at 
the field edges and this could possibly be a result of slight differences between 
gantry angles during film irradiation. Similar differences at the field edges were 
observed for the small field sizes. This is a result of small differences in the field size 
diameter between measurement and calculation. 
This project has showed that 2D dose plane validation is possible with non-
standard measurement conditions including inhomogeneous media. Obtaining doses 
at the build-up region, surface and media interfaces are possible with this 
measurement method. Further investigation of the build-up region should be 
performed by a full Monte Carlo simulation as a baseline for comparison, to establish 
whether limitations of the XiO beam modelling are responsible for the differences 
between XiO eMC and EBT3 film in this region. 
 
6.4 Future work 
The method described in this work is not only limited to electron beam radiotherapy 
but could be extended to other treatment modalities such as Superficial X-Ray 
Therapy (SXRT) and Brachytherapy. SXRT uses kilovoltage x-ray beams in the range of 
40 – 300 kV to treat superficial tumours. Due to the limitations of ionisation 
chambers, depth-dose curves for kilovoltage x-ray beams are difficult to measure 
especially near the surface. The film method described in this project could be used 
to measure depth dose curves in regions where ionisation chambers lack accuracy.  
A preliminary study has been undertaken to compare planned and measured 
skin doses for breast radiation therapy using radiochromic film. Skin reaction is the 
primary acute toxicity experienced by patients undergoing breast radiation therapy. 
Based on this study, treatment planning systems do not provide an accurate 
estimate of surface dose delivery especially for curved structures. The aim of this 
study is to determine the accuracy in calculating skin doses for breast cancer patient 
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utilising an IMRT Head & Torso Freepoint phantom (CIRS, Norfolk, VA). The results of 
this study will be the subject of a future publication. 
In preparation for the move of Peter MacCallum Cancer Centre to the new 
Victorian Comprehensive Cancer Centre in Parkville, the method described in this 
work was employed to re-commission the Varian Eclipse™ electron Monte Carlo 
algorithm for the new TrueBeam™ linear accelerators. A new and improved film 
water tank is currently being constructed and will be used for this commissioning 
project. The Parkville commissioning project provides an opportunity to compare 
film measurements with two different treatment planning systems (XiO and Eclipse).  
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